<SEC-DOCUMENT>0001171843-21-004469.txt : 20210622
<SEC-HEADER>0001171843-21-004469.hdr.sgml : 20210622
<ACCEPTANCE-DATETIME>20210622161519
ACCESSION NUMBER:		0001171843-21-004469
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210616
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210622
DATE AS OF CHANGE:		20210622

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Anika Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000898437
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				043145961
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-14027
		FILM NUMBER:		211035531

	BUSINESS ADDRESS:	
		STREET 1:		32 WIGGINS AVENUE
		CITY:			BEDFORD
		STATE:			MA
		ZIP:			01730
		BUSINESS PHONE:		(781) 457-9000

	MAIL ADDRESS:	
		STREET 1:		32 WIGGINS AVENUE
		CITY:			BEDFORD
		STATE:			MA
		ZIP:			01730

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA THERAPEUTICS INC
		DATE OF NAME CHANGE:	19970114

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANIKA RESEARCH INC
		DATE OF NAME CHANGE:	19930309
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k_062121.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full" xmlns:ANIK="http://ANIK/20210616">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_023_IFRS%2D2020 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_ANIK_ANIK_20210616 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20210616_20210616 -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0000898437 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
  <ix:hidden>
    <ix:nonNumeric contextRef="From2021-06-16to2021-06-16" name="dei:EntityCentralIndexKey">0000898437</ix:nonNumeric>
    <ix:nonNumeric contextRef="From2021-06-16to2021-06-16" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
    </ix:hidden>
  <ix:references>
    <link:schemaRef xlink:href="anik-20210616.xsd" xlink:type="simple" />
    </ix:references>
  <ix:resources>
    <xbrli:context id="From2021-06-16to2021-06-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0000898437</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-16</xbrli:startDate>
        <xbrli:endDate>2021-06-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    </ix:resources>
  </ix:header>
</div>


<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">UNITED STATES</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">SECURITIES AND EXCHANGE COMMISSION</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">Washington, D.C. 20549</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">FORM <span id="xdx_90E_edei--DocumentType_c20210616__20210616_zDizlkVlzfcl"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" name="dei:DocumentType">8-K</ix:nonNumeric></span></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">CURRENT REPORT</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">PURSUANT TO SECTION 13 OR 15(d)</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">OF THE SECURITIES EXCHANGE ACT OF 1934</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">Date of Report (Date of earliest event reported): <span id="xdx_902_edei--DocumentPeriodEndDate_c20210616__20210616_zLjeYvpE2Bqk"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">June 16, 2021</ix:nonNumeric></span></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><span id="xdx_90A_edei--EntityRegistrantName_c20210616__20210616_z9cMHPqROW4g"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" name="dei:EntityRegistrantName">Anika Therapeutics, Inc.</ix:nonNumeric></span></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><i>(Exact name of registrant as specified in its charter)</i></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="text-align: center; width: 33%; font-size: 10pt"><span id="xdx_909_edei--EntityIncorporationStateCountryCode_c20210616__20210616_zDW2pYX5TmKg"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="text-align: center; width: 33%; font-size: 10pt"><span id="xdx_90A_edei--EntityFileNumber_c20210616__20210616_zyZWiljb5ozi"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" name="dei:EntityFileNumber">000-21326</ix:nonNumeric></span></td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="text-align: center; width: 32%; font-size: 10pt"><span id="xdx_903_edei--EntityTaxIdentificationNumber_c20210616__20210616_zFSbtqqolOF4"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" name="dei:EntityTaxIdentificationNumber">04-3145961</ix:nonNumeric></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><i>(State or other jurisdiction of</i></td><td style="text-align: center; font-size: 10pt; vertical-align: top"><i>&#160;</i></td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><p style="margin: 0pt 0; font-size: 10pt"><i>Commission
                                         file number</i></p></td><td style="text-align: center; font-size: 10pt; font-style: italic; vertical-align: top"><i>&#160;</i></td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><i>(I.R.S. Employer</i></td></tr>
<tr style="vertical-align: bottom">
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><i>&#160;incorporation or organization)</i></td><td style="text-align: center; font-size: 10pt; vertical-align: top"><i>&#160;</i></td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><i>&#160;</i></td><td style="text-align: center; font-size: 10pt; font-style: italic; vertical-align: top"><i>&#160;</i></td>
    <td style="vertical-align: top; font-size: 10pt; text-align: center"><i>Identification No.)</i></td></tr>
</table>


<p style="margin: 0pt 0; font-size: 10pt"></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><span id="xdx_907_edei--EntityAddressAddressLine1_c20210616__20210616_zZ0uJi3dDYr9"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" name="dei:EntityAddressAddressLine1">32 Wiggins Avenue</ix:nonNumeric></span>, <span id="xdx_906_edei--EntityAddressCityOrTown_c20210616__20210616_zHeG5pbmAyWc"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" name="dei:EntityAddressCityOrTown">Bedford</ix:nonNumeric></span>, <span id="xdx_908_edei--EntityAddressStateOrProvince_c20210616__20210616_zNYElWdatyia"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" name="dei:EntityAddressStateOrProvince">MA</ix:nonNumeric></span> <span id="xdx_901_edei--EntityAddressPostalZipCode_c20210616__20210616_z9F2GWs5T9za"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" name="dei:EntityAddressPostalZipCode">01730</ix:nonNumeric></span></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><i>(Address of principal
executive offices) (Zip code)</i></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"> <span id="xdx_909_edei--CityAreaCode_c20210616__20210616_zoRwLSDiqCBi"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" name="dei:CityAreaCode">(781)</ix:nonNumeric></span>
<span id="xdx_903_edei--LocalPhoneNumber_c20210616__20210616_zKnFDZw7607i"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" name="dei:LocalPhoneNumber">457-9000</ix:nonNumeric></span></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><i></i></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><i></i></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><i>Registrant&#8217;s telephone number, including area code:</i></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><i>&#160;</i></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">Not applicable</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"><i>(Former name or former address, if changed
since last report)</i></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center"></p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: justify">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"> <span id="xdx_90B_edei--WrittenCommunications_c20210616__20210616_zFvKAFZIhBSl"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span> <span style="font-size: 10pt">Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)</span></p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 4.5pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><span id="xdx_902_edei--SolicitingMaterial_c20210616__20210616_zK0qHFK3a8G9"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span> <span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)</span></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><span id="xdx_902_edei--PreCommencementTenderOffer_c20210616__20210616_zduX1lJ4iK84"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span> <span style="font-size: 10pt">Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><span id="xdx_902_edei--PreCommencementIssuerTenderOffer_c20210616__20210616_z8SEZVShlIWh"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span> <span style="font-size: 10pt">Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; font-size: 10pt">
<tr>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 44%; text-align: center"><b>Title of each class</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 18%; text-align: center"><b>Trading Symbol(s)</b></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 36%; text-align: center"><b>Name of each exchange on which registered</b></td></tr>
<tr>
    <td style="vertical-align: top; text-align: center"><span id="xdx_904_edei--Security12bTitle_c20210616__20210616_zMD9ICguYix1"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" name="dei:Security12bTitle">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span id="xdx_902_edei--TradingSymbol_c20210616__20210616_zlitNyzzlua9"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" name="dei:TradingSymbol">ANIK</ix:nonNumeric></span></td>
    <td>&#160;</td>
    <td style="vertical-align: top; text-align: center"><span id="xdx_90B_edei--SecurityExchangeName_c20210616__20210616_zhAsB2DUT5ka"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">NASDAQ Global Select Market</ix:nonNumeric></span></td></tr>
</table>
<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">Indicate by check mark whether the registrant is an emerging growth company as defined
in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p>

<p style="margin: 0pt 0; font-size: 10pt"><span style="font-size: 10pt">Emerging growth company <span id="xdx_904_edei--EntityEmergingGrowthCompany_c20210616__20210616_zKK9wrOI2BBf"><ix:nonNumeric contextRef="From2021-06-16to2021-06-16" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><span style="font-size: 10pt">If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 4pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>



<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><p style="margin-top: 0; margin-bottom: 0"><b></b></p>
                                                 <p style="margin-top: 0; margin-bottom: 0"><b>Item 5.02.</b></p></td><td><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.</b></td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><i>Amendment to 2017 Omnibus Incentive Plan</i></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">On March 17, 2021, the board of directors adopted and approved, subject to stockholder
approval, an amendment to the Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan, as amended, or the Amendment. Stockholders
approved the Amendment at our Annual Meeting of Stockholders held on June 16, 2021 (the &#8220;Annual Meeting&#8221;), as described
under Item 5.07 below. The Amendment increases the number of shares of common stock reserved under the 2017 Omnibus Incentive Plan
by 1,100,000 from 3,500,000 to 4,600,000. Additionally, the Amendment provides that all 4,600,000 shares authorized under the plan
may be granted as Incentive Stock Options in accordance with Section 422 of the Internal Revenue Code of 1986. No other provisions
of the 2017 Omnibus Incentive Plan were amended by the Amendment.</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">A summary of the principle features of the 2017 Omnibus Incentive Plan is included in
the definitive proxy statement filed with the SEC on April 30, 2021. The foregoing description is qualified in its entirety by
reference to the text of the 2017 Omnibus Incentive Plan, as amended by the stockholders at the Annual Meeting, which is filed
as an exhibit to this Form 8-K and incorporated herein by reference.</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"><i>2021 Employee Stock Purchase Plan</i></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">On March 17, 2021, the board of directors adopted and approved, subject to stockholder
approval, the Anika Therapeutics, Inc. 2021 Employee Stock Purchase Plan, or the ESPP. Stockholders approved the ESPP at our Annual
Meeting, as described under Item 5.07 below. The number of shares of common stock reserved under the ESPP is 200,000. Additionally,
the ESPP is intended to constitute an &#8220;employee stock purchase plan&#8221; within the meaning of Section 423(b) of the Internal
Revenue Code of 1986.</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">A summary of the principle features of the 2021 Employee Stock Purchase Plan is included
in the definitive proxy statement filed with the SEC on April 30, 2021. The foregoing description is qualified in its entirety
by reference to the text of the 2021 Employee Stock Purchase Plan as approved by the stockholders at the Annual Meeting, which
is filed as an exhibit to this Form 8-K and incorporated herein by reference.</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 5.07.</b></td><td><b>Submission of Matters to a Vote of Security Holders.</b></td></tr></table>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">We held our 2021 Annual Meeting of Stockholders on June 16, 2021. The board of directors
solicited proxies pursuant to a proxy statement that we filed on April 30, 2021 with the Securities and Exchange Commission under
Section 14(a) of the Securities Exchange Act of 1934. There was no solicitation in opposition to the board&#8217;s solicitation.
A total of 12,728,227 shares of common stock were present in person or by proxy at the meeting, representing 88.6% of the voting
power entitled to vote at the meeting. Each share of common stock was entitled to one vote with respect to each matter submitted
to a vote at the meeting, and the voting results reported below are final.</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">The matters considered and voted on by the stockholders at the meeting and the votes
of the stockholders were as follows:</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">PROPOSAL 1</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">Stockholders voted as follows with respect to election of each of the nominee for directors
identified in the proxy statement:</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Nominee</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">For</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Against</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Abstain</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Broker Non-Votes</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="border-bottom: Black 1pt solid; width: 36%; font-size: 10pt; text-align: left; padding-bottom: 1pt">Stephen O. Richard</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 15%; font-size: 10pt; text-align: center">11,776,072</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 15%; font-size: 10pt; text-align: center">38,256</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 15%; font-size: 10pt; text-align: center">34,322</td><td style="width: 1%; font-size: 10pt; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 15%; font-size: 10pt; text-align: center">879,577</td></tr>
<tr style="background-color: White">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">Jeffery S. Thompson</td><td style="font-size: 10pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">11,564,230</td><td style="font-size: 10pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">250,298</td><td style="font-size: 10pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">34,122</td><td style="font-size: 10pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; text-align: center">879,577</td></tr>
</table>

<p style="margin: 0pt 0; font-size: 10pt"></p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">As a result of this vote, Messrs. Richard and Thompson were elected as Class I directors
to serve until the 2024 Annual Meeting of Stockholders and until each of his successors is duly elected and qualified.</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 4pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">PROPOSAL 2</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">Stockholders voted as follows with respect to approval of the amendment to the Anika
Therapeutics, Inc. 2017 Omnibus Incentive Plan:</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">For</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Against</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Abstain</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="3" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Broker Non-Votes</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 1%; font-size: 10pt; text-align: center">&#160;</td><td style="width: 23%; font-size: 10pt; text-align: center">6,853,563</td><td style="width: 1%; font-size: 10pt; text-align: center">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: center">&#160;</td><td style="width: 22%; font-size: 10pt; text-align: center">4,948,129</td><td style="width: 1%; font-size: 10pt; text-align: center">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: center">&#160;</td><td style="width: 22%; font-size: 10pt; text-align: center">46,958</td><td style="width: 1%; font-size: 10pt; text-align: center">&#160;</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: center">&#160;</td><td style="width: 22%; font-size: 10pt; text-align: center">879,577</td><td style="width: 1%; font-size: 10pt; text-align: center">&#160;</td></tr>
</table>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">PROPOSAL 3</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">Stockholders voted as follows with respect to approval of the Anika Therapeutics, Inc.
2021 Employee Stock Purchase Plan:</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">For</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Against</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Abstain</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Broker Non-Votes</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="width: 25%; font-size: 10pt; text-align: center">11,754,424</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 24%; font-size: 10pt; text-align: center">71,355</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 24%; font-size: 10pt; text-align: center">22,871</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 24%; font-size: 10pt; text-align: center">879,577</td></tr>
</table>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">PROPOSAL 4</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">Stockholders voted as follows with respect to ratification of the appointment of Deloitte
&amp; Touche LLP as our independent registered public accounting firm for 2021:</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">For</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Against</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Abstain</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Broker Non-Votes</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="width: 25%; font-size: 10pt; text-align: center">12,690,638</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 24%; font-size: 10pt; text-align: center">17,475</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 24%; font-size: 10pt; text-align: center">20,114</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 24%; font-size: 10pt; text-align: center">&#9472;</td></tr>
</table>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">PROPOSAL 5</p>

<p style="margin: 0pt 0; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt">Stockholders voted, on an advisory basis, as follows with respect to compensation paid
to our Named Executive Officers as disclosed pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and
Analysis, compensation tables and narrative discussion set forth in the Proxy Statement of the Meeting:</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%">
<tr>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">For</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Against</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Abstain</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Broker Non-Votes</td></tr>
<tr style="background-color: rgb(204,238,255)">
    <td style="width: 25%; font-size: 10pt; text-align: center">9,121,886</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 24%; font-size: 10pt; text-align: center">2,705,453</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 24%; font-size: 10pt; text-align: center">21,311</td><td style="width: 1%; font-size: 10pt">&#160;</td>
    <td style="width: 24%; font-size: 10pt; text-align: center">879,577</td></tr>
</table>

<p style="margin: 0pt 0; font-size: 10pt"><b>&#160;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b></b></p>

<p style="margin: 0pt 0; font-size: 10pt"><b></b></p>

<table cellpadding="0" cellspacing="0" style="width: 100%; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
    <td style="width: 0"></td>
    <td style="width: 1in"><b>Item 9.01.</b></td>
    <td><b>Financial Statements and Exhibits.</b></td></tr>
</table>

<p style="margin: 0pt 0; font-size: 10pt"><b>&#160;</b></p>

<p style="margin: 0pt 0; font-size: 10pt"></p>

<p style="margin: 0pt 0; font-size: 10pt"></p>

<p style="margin: 0pt 0; font-size: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exhibits.</p>

<p style="margin: 0pt 0; font-size: 10pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; width: 11%"><span style="font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="width: 2%; text-align: center">&#160;</td>
    <td style="border-bottom: Black 1pt solid; width: 87%; text-align: center"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
<tr>
    <td style="vertical-align: top"><a href="exh_991.htm">99.1</a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="exh_991.htm">Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan (as amended effective June 16, 2021)</a></td></tr>
<tr>
    <td style="vertical-align: top"><a href="exh_992.htm">99.2</a></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="vertical-align: top"><a href="exh_992.htm">Anika Therapeutics, Inc. 2021 Employee Stock Purchase Plan (adopted June 16, 2021)</a></td></tr>
</table>
<p style="margin: 0pt 0; color: #000033; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt; text-align: center"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 4pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0pt 0; color: #000033; font-size: 10pt; text-align: center"></p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt; text-align: center"><b>SIGNATURE</b></p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt; text-align: center">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&#160;</p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in"></p>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: top; text-align: left">
    <td>&#160;</td>
    <td colspan="2"><b>Anika Therapeutics, Inc.</b></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td style="width: 51%">&#160;</td>
    <td style="width: 5%">&#160;</td>
    <td style="width: 25%">&#160;</td>
    <td style="width: 19%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>Date: June 22, 2021</td>
    <td>By:</td>
    <td style="border-bottom: Black 1pt solid">/s/ <span style="font-variant: small-caps">Cheryl R. Blanchard</span></td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>Cheryl R. Blanchard</td>
    <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>President and Chief Executive Officer</td>
    <td>&#160;</td></tr>
</table>

<p style="margin: 0pt 0; font-size: 10pt; text-indent: 0in">&#160;</p>

<p style="margin: 0pt 0 0pt 3.25in; font-size: 10pt"></p>

<p style="margin: 0pt 0 0pt 3.25in; font-size: 10pt"></p>

<p style="margin: 0pt 12.1pt 0pt 0; font-size: 10pt"></p>

<p style="margin: 0pt 0 0pt 3.5in; font-size: 10pt"></p>

<p style="margin: 0pt 0 0pt 3.5in; font-size: 10pt"></p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt">&#160;</p>

<p style="margin: 0pt 0; color: #000033; font-size: 10pt"></p>

<!-- Field: Rule-Page --><div style="margin: 3pt auto; width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0pt 0; color: #000033; font-size: 10pt"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjd0KgkAQhZ/Adxj2WsoV7MLLpCSyCJHodskxlnRHZtd+Hqm3bFWi4cAwc+abI0QoctrqFhku67KACru+VQ6hxAYZzRX9Rbbbp+B7iTdtHSvjpvEHZuQZ9EyySK5+P10+tMU6hWi1jKUXRHEqEzgdRDD6GZlG12icVi0oU8OJqWeNTvF7/lCpFxnq3lPSGdlqMinIRTTbH4gjGcORHupJfLdQFJkIwqkCkTMN/RgzWEcdbFrsfJad0b+CL9yySRc= -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exh_991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0"><B>EXHIBIT 99.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0"><FONT STYLE="text-transform: uppercase">ANIKA
THERAPEUTICS, INC.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: center; text-indent: 0in; margin: 0pt 0">2017 OMNIBUS INCENTIVE PLAN</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">(As amended June
16, 2021)</FONT></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Anika Therapeutics, Inc. sets forth herein the
terms of its 2017 Omnibus Incentive Plan.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.</TD><TD STYLE="text-align: justify">PURPOSE</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Plan is intended to enhance the ability
of the Company and its Affiliates to attract and retain highly qualified officers, Non-employee Directors, employees, consultants
and advisors, and to motivate such individuals to serve the Company and its Affiliates and to expend maximum effort to improve
the business results and earnings of the Company, by providing to such persons an opportunity to acquire or increase a direct proprietary
interest in the operations and future success of the Company. To this end, the Plan provides for the grant of stock options, stock
appreciation rights (&ldquo;<B>SARs</B>&rdquo;), restricted stock, restricted stock units (&ldquo;<B>RSUs</B>&rdquo;), unrestricted
stock, other share-based awards and cash awards. Any of these awards may, but need not, be made as performance incentives to reward
attainment of performance goals in accordance with the terms hereof. Upon the Plan becoming effective, no further awards shall
be made under the Prior Plan.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.</TD><TD STYLE="text-align: justify">DEFINITIONS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">For purposes of interpreting the Plan and related
documents (including Award Agreements), the following definitions shall apply:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Acquiror<FONT STYLE="font-weight: normal">&rdquo;
shall have the meaning set forth in </FONT>Section&nbsp;15.2.1<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Affiliate<FONT STYLE="font-weight: normal">&rdquo;
means any company or other trade or business that &ldquo;controls,&rdquo; is &ldquo;controlled by&rdquo; or is &ldquo;under common
control with&rdquo; the Company within the meaning of Rule 405 of Regulation C under the Securities Act, including any Subsidiary.
</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Annual
Incentive Award<FONT STYLE="font-weight: normal">&rdquo; means a cash-based Performance Award with a performance period that is
the Company&rsquo;s fiscal year or other 12-month (or shorter) performance period as specified under the terms of the Award as
approved by the Board.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Award<FONT STYLE="font-weight: normal">&rdquo;
means a grant under the Plan of an Option, SAR, Restricted Stock, RSU, Other Share-based Award or cash award. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Award
Agreement<FONT STYLE="font-weight: normal">&rdquo; means a written agreement between the Company and a Participant, or notice from
the Company or an Affiliate to a Participant that evidences and sets out the terms of an Award. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&ldquo;<B>Board</B>&rdquo; means the Board of Directors of the Company<B>.</B></P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Business
Combination<FONT STYLE="font-weight: normal">&rdquo; shall have the meaning set forth in </FONT>Section&nbsp;15.2.2<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Cause<FONT STYLE="font-weight: normal">&rdquo;
shall be defined as that term is defined in the Participant&rsquo;s offer letter or other applicable employment agreement; or,
if there is no such definition, &ldquo;Cause&rdquo; means, as determined by the Company in its sole discretion and unless otherwise
provided in the applicable Award Agreement: (i) any material breach by the Participant of any agreement between the Participant
and the Company; (ii) the conviction of or plea of nolo contendere by the Participant to a felony or a crime involving moral turpitude;
or (iii) any material misconduct or willful and deliberate non-performance (other than by reason of disability) by the Participant
of the Participant&rsquo;s duties to the Company. A Separation from Service for Cause shall be deemed to include a determination
by the Company in its sole discretion following a Participant&rsquo;s Separation from Service that circumstances existing prior
to such Separation from Service would have entitled the Company or an Affiliate to have terminated the Participant&rsquo;s service
for Cause. All rights a Participant has or may have under the Plan shall be suspended automatically during the pendency of any
investigation by the Company, or during any negotiations between the Company and the Participant, regarding any actual or alleged
act or omission by the Participant of the type described in the applicable definition of Cause.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&ldquo;<B>Change in Control</B>&rdquo; shall have the meaning set
forth in <B>Section&nbsp;15.2.2</B>.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&ldquo;<B>Code</B>&rdquo; means the Internal Revenue Code of 1986.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&ldquo;<B>Committee</B>&rdquo; means the Compensation Committee of
the Board, or such other committee as determined by the Board. The Compensation Committee of the Board may designate a subcommittee
of its members to serve as the Committee (to the extent the Board has not designated another person, committee or entity as the
Committee). The Board will cause the Committee to satisfy the applicable requirements of any securities exchange on which the Common
Stock may then be listed. For purposes of Awards to Covered Employees intended to qualify as Performance-Based Compensation, to
the extent required by Section&nbsp;162(m), Committee means all of the members of the Compensation Committee who are &ldquo;outside
directors&rdquo; within the meaning of Section&nbsp;162(m). For purposes of Awards to Participants who are subject to Section&nbsp;16
of the Exchange Act, Committee means all of the members of the Compensation Committee who are &ldquo;non-employee directors&rdquo;
within the meaning of Rule 16b-3 adopted under the Exchange Act.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&ldquo;<B>Company</B>&rdquo; means Anika Therapeutics, Inc., a Massachusetts
corporation, or any successor corporation.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&ldquo;<B>Common Stock</B>&rdquo; means the common stock of the Company.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Consultant<FONT STYLE="font-weight: normal">&rdquo;
means a consultant or advisor that provides bona fide services to the Company or any Affiliate and who qualifies as a consultant
or advisor under Form S-8.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Covered
Employee<FONT STYLE="font-weight: normal">&rdquo; means a Participant who is a &ldquo;covered employee&rdquo; within the meaning
of Section&nbsp;162(m) as qualified by </FONT>Section&nbsp;12.4<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Disability<FONT STYLE="font-weight: normal">&rdquo;
shall be defined as that term is defined in the Participant&rsquo;s offer letter or other applicable employment agreement; or,
if there is no such definition, &ldquo;Disability&rdquo; means, as determined by the Company in its sole discretion and unless
otherwise provided in the applicable Award Agreement, the Participant is unable to perform each of the essential duties of such
Participant&rsquo;s position by reason of a medically determinable physical or mental impairment which is potentially permanent
in character or which can be expected to last for a continuous period of not less than 12 months; <I>provided</I>, <I>however</I>,
that, with respect to rules regarding expiration of an Incentive Stock Option following termination of the Participant&rsquo;s
employment, &ldquo;Disability&rdquo; means &ldquo;permanent and total disability&rdquo; as set forth in Code Section&nbsp;22(e)(3).</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Effective
Date<FONT STYLE="font-weight: normal">&rdquo; means June 13, 2017, the date the Plan was approved by the Stockholders. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Exchange
Act<FONT STYLE="font-weight: normal">&rdquo; means the Securities Exchange Act of 1934.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Fair
Market Value<FONT STYLE="font-weight: normal">&rdquo; means, as of any date, the value of the Common Stock as determined below.
If the Common Stock is listed on any established stock exchange or a national market system, including without limitation, the
New York Stock Exchange or the NASDAQ Stock Market, the Fair Market Value shall be the closing price of a share of Common Stock
(or if no sales were reported the closing price on the date immediately preceding such date) as quoted on such exchange or system
on the day of determination. In the absence of an established market for the Common Stock, the Fair Market Value shall be determined
in good faith by the Board and such determination shall be conclusive and binding on all persons. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Family
Member<FONT STYLE="font-weight: normal">&rdquo; means a person who is a spouse, former spouse, child, stepchild, grandchild, parent,
stepparent, grandparent, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother, sister, brother-in-law
or sister-in-law, including adoptive relationships, of the applicable individual, any person sharing the applicable individual&rsquo;s
household (other than a tenant or employee), a trust in which any one or more of these persons have more than 50% of the beneficial
interest, a foundation in which any one or more of these persons (or the applicable individual) control the management of assets,
and any other entity in which one or more of these persons (or the applicable individual) own more than 50% of the voting interests.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Grant
Date<FONT STYLE="font-weight: normal">&rdquo; means the latest to occur of (i)&nbsp;the date as of which the Board approves an
Award, (ii)&nbsp;the date on which the recipient of an Award first becomes eligible to receive an Award under </FONT>Section&nbsp;6
<FONT STYLE="font-weight: normal">or (iii)&nbsp;such other date as may be specified by the Board in the Award Agreement. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Incentive
Stock Option<FONT STYLE="font-weight: normal">&rdquo; means an &ldquo;incentive stock option&rdquo; within the meaning of Code
Section&nbsp;422. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Incumbent
Directors<FONT STYLE="font-weight: normal">&rdquo;shall have the meaning set forth in </FONT>Section&nbsp;15.2.2<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>New
Shares<FONT STYLE="font-weight: normal">&rdquo; shall have the meaning set forth in </FONT>Section&nbsp;15.1<FONT STYLE="font-weight: normal">.
</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Non-employee
Director<FONT STYLE="font-weight: normal">&rdquo; means a member of the Board or the board of directors of an Affiliate, in each
case who is not an officer or employee of the Company or any Affiliate. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Nonqualified
Stock Option<FONT STYLE="font-weight: normal">&rdquo; means an Option that is not an Incentive Stock Option. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Option<FONT STYLE="font-weight: normal">&rdquo;
means an option to purchase one or more Shares pursuant to the Plan. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Option
Price<FONT STYLE="font-weight: normal">&rdquo; means the exercise price for each Share subject to an Option. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Other
Share-based Awards<FONT STYLE="font-weight: normal">&rdquo; means Awards consisting of Share units, or other Awards, valued in
whole or in part by reference to, or otherwise based on, Shares.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Participant<FONT STYLE="font-weight: normal">&rdquo;
shall mean a person who, as a Service Provider, has been granted an Award under the Plan; <I>provided</I>, <I>however</I>, that
in the case of the death or Disability of a Participant, the term &ldquo;Participant&rdquo; refers to the Participant&rsquo;s estate
or other legal representative acting in a fiduciary capacity on behalf of the Participant under applicable state law and court
supervision. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Performance
Award<FONT STYLE="font-weight: normal">&rdquo; means an Award made subject to the attainment of performance goals (as described
in </FONT>Section&nbsp;12<FONT STYLE="font-weight: normal">) over a performance period established by the Committee, and includes
an Annual Incentive Award.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Performance-Based
Compensation<FONT STYLE="font-weight: normal">&rdquo; means &ldquo;performance-based compensation&rdquo; under Section&nbsp;162(m).</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Plan<FONT STYLE="font-weight: normal">&rdquo;
means this Anika Therapeutics, Inc. 2017 Omnibus Incentive Plan. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Policy<FONT STYLE="font-weight: normal">&rdquo;
shall have the meaning set forth in </FONT>Section&nbsp;3.2.2<FONT STYLE="font-weight: normal">. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Prior
Plan<FONT STYLE="font-weight: normal">&rdquo; means the Anika Therapeutics, Inc. Second Amended and Restated 2003 Stock Option
and Incentive Plan, as amended. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Purchase
Price<FONT STYLE="font-weight: normal">&rdquo; means the purchase price for each Share pursuant to a grant of Restricted Stock.
</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Restricted
Stock<FONT STYLE="font-weight: normal">&rdquo; means restricted Shares, awarded to a Participant pursuant to </FONT>Section&nbsp;10<FONT STYLE="font-weight: normal">.
</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Restricted
Stock Unit<FONT STYLE="font-weight: normal">&rdquo; or &ldquo;</FONT>RSU<FONT STYLE="font-weight: normal">&rdquo; means a bookkeeping
entry representing the equivalent of Shares, awarded to a Participant pursuant to </FONT>Section&nbsp;10<FONT STYLE="font-weight: normal">.
</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>SAR
Exercise Price<FONT STYLE="font-weight: normal">&rdquo; means the per Share exercise price of a SAR granted to a Participant under
</FONT>Section&nbsp;9<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>SEC<FONT STYLE="font-weight: normal">&rdquo;
means the United States Securities and Exchange Commission.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Section&nbsp;162(m)<FONT STYLE="font-weight: normal">&rdquo;
means Code Section&nbsp;162(m).</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Section&nbsp;409A<FONT STYLE="font-weight: normal">&rdquo;
means Code Section&nbsp;409A. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Securities
Act<FONT STYLE="font-weight: normal">&rdquo; means the Securities Act of 1933.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Separation
from Service<FONT STYLE="font-weight: normal">&rdquo; means the termination of the applicable Participant&rsquo;s employment with,
and performance of services for, the Company and each Affiliate. A Participant employed by, or performing services for, an Affiliate
or a division of the Company or an Affiliate shall not be deemed to incur a Separation from Service if such Affiliate or division
ceases to be an Affiliate or division of the Company, as the case may be, and the Participant immediately thereafter becomes an
employee of (or service provider to), or member of the board of directors of, the Company or an Affiliate or a successor company
or an affiliate or subsidiary thereof. Approved temporary absences from employment because of illness, vacation or leave of absence
and transfers among the Company and its Affiliates shall not be considered Separations from Service. Notwithstanding the foregoing,
with respect to any Award that constitutes nonqualified deferred compensation under Section&nbsp;409A, &ldquo;Separation from Service&rdquo;
shall mean a &ldquo;separation from service&rdquo; as defined under Section&nbsp;409A.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Service
Period<FONT STYLE="font-weight: normal">&rdquo; shall have the meaning set forth in </FONT>Section&nbsp;10.1<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Service
Provider<FONT STYLE="font-weight: normal">&rdquo; means an employee, officer, Non-employee Director or Consultant of the Company
or an Affiliate. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Share<FONT STYLE="font-weight: normal">&rdquo;
means a share of Common Stock.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Stock
Appreciation Right<FONT STYLE="font-weight: normal">&rdquo; or &ldquo;</FONT>SAR<FONT STYLE="font-weight: normal">&rdquo; means
a right granted to a Participant pursuant to </FONT>Section&nbsp;9<FONT STYLE="font-weight: normal">. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Stockholders<FONT STYLE="font-weight: normal">&rdquo;
means the stockholders of the Company.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Subsidiary<FONT STYLE="font-weight: normal">&rdquo;
means any &ldquo;subsidiary corporation&rdquo; of the Company within the meaning of Code Section&nbsp;424(f). </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Substitute
Award<FONT STYLE="font-weight: normal">&rdquo; means any Award granted in assumption of or in substitution for an award of a company
or business acquired by the Company or an Affiliate or with which the Company or an Affiliate combines. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Ten
Percent Stockholder<FONT STYLE="font-weight: normal">&rdquo; means an individual who owns more than 10% of the total combined voting
power of all classes of outstanding stock of the Company, its parent or any of its Subsidiaries. In determining stock ownership,
the attribution rules of Code Section&nbsp;424(d) shall be applied. </FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Termination
Date<FONT STYLE="font-weight: normal">&rdquo; means the date that is 10 years after the Effective Date, unless the Plan is earlier
terminated by the Board under </FONT>Section&nbsp;5.2<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0"><FONT STYLE="font-weight: normal">&ldquo;</FONT>Voting
Securities<FONT STYLE="font-weight: normal">&rdquo; shall have the meaning set forth in </FONT>Section&nbsp;15.2.2<FONT STYLE="font-weight: normal">.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.</TD><TD STYLE="text-align: justify">ADMINISTRATION OF THE PLAN</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
General</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Board shall have such powers and authorities
related to the administration of the Plan as are consistent with the Company&rsquo;s certificate of incorporation and bylaws and
applicable law. The Board shall have the power and authority to delegate its responsibilities hereunder to the Committee, which
shall have full authority to act in accordance with its charter, and with respect to the power and authority of the Board to act
hereunder, all references to the Board shall be deemed to include a reference to the Committee, unless such power or authority
is specifically reserved by the Board. Except as specifically provided in <B>Section&nbsp;14</B> or as otherwise may be required
by applicable law, regulatory requirement or the certificate of incorporation or the bylaws of the Company, the Board shall have
full power and authority to take all actions and to make all determinations required or provided for under the Plan, any Award
or any Award Agreement, and shall have full power and authority to take all such other actions and make all such other determinations
not inconsistent with the specific terms and provisions of the Plan that the Board deems to be necessary or appropriate to the
administration of the Plan. The Committee shall administer the Plan; <I>provided</I>, <I>however</I>, the Board shall retain the
right to exercise the authority of the Committee to the extent consistent with applicable law and the applicable requirements of
any securities exchange on which the Common Stock may then be listed. All actions, determinations and decisions by the Board or
the Committee under the Plan or any Award Agreement, or with respect to any Award, shall be in the sole discretion of the Board
and shall be final, binding and conclusive on all persons. Without limitation, the Board shall have full and final power and authority,
subject to the other terms of the Plan, to:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">designate Participants;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">determine the type or types of Awards to be made to Participants;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">determine the number of Shares to be subject to an Award;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">establish the terms of each Award (including the Option Price of any Option, the nature and duration
of any restriction or condition (or provision for lapse thereof) relating to the vesting, exercise, transfer or forfeiture of an
Award or the Shares subject thereto and any terms or conditions that may be necessary to qualify Options as Incentive Stock Options);</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">subject to applicable law, delegate its authority and duties to the Chief Executive Officer with
respect to the granting of Options to individuals who are not Covered Employees or &ldquo;insiders&rdquo; within the meaning of
Section 16 of the Exchange Act. Any such delegation by the Board shall include a limitation as to the amount of Options that may
be granted during the period of the delegation and shall contain guidelines as to the determination of the exercise price and the
vesting criteria. The Board may revoke or amend the terms of a delegation at any time but such action shall not invalidate any
prior actions of the Board&rsquo; delegate or delegates that were consistent with the terms of the Plan.;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(vi)</TD><TD STYLE="text-align: justify">prescribe the form of each Award Agreement; and</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(vii)</TD><TD STYLE="text-align: justify">amend, modify or supplement the terms of any outstanding Award including the authority, in order
to effectuate the purposes of the Plan, to modify Awards to foreign nationals or individuals who are employed outside the United&nbsp;States
to recognize differences in local law, tax policy or custom.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Separation from Service for Cause; Clawbacks</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">3.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Separation from Service for Cause</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The Company may annul an Award if the Participant
incurs a Separation from Service for Cause.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">3.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Clawbacks</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">All awards, amounts or benefits received or outstanding
under the Plan shall be subject to clawback, cancellation, recoupment, rescission, payback, reduction or other similar action in
accordance with the terms of any Company clawback or similar policy (the &ldquo;<B>Policy</B>&rdquo;) or any applicable law related
to such actions, as may be in effect from time to time. A Participant&rsquo;s acceptance of an Award shall be deemed to constitute
the Participant&rsquo;s acknowledgement of and consent to the Company&rsquo;s application, implementation and enforcement of any
applicable Policy that may apply to the Participant, whether adopted prior to or following the Effective Date, and any provision
of applicable law relating to clawback, cancellation, recoupment, rescission, payback or reduction of compensation, and the Participant&rsquo;s
agreement that the Company may take such actions as may be necessary to effectuate any such policy or applicable law, without further
consideration or action.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0">3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Deferral Arrangement</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Board may permit or require the deferral
of any Award payment into a deferred compensation arrangement, subject to such rules and procedures as it may establish and in
accordance with Section&nbsp;409A, which may include provisions for the payment or crediting of interest or dividend equivalents
as provided in <B>Section 17.10</B>, including converting such credits into deferred Share units.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">3.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
No Liability</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">No member of the Board or of the Committee shall
be liable for any action or determination made in good faith with respect to the Plan, any Award or Award Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">3.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Book Entry</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Notwithstanding any other provision of the Plan
to the contrary, the Company may elect to satisfy any requirement under the Plan for the delivery of stock certificates through
the use of book entry.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">3.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
No Repricing</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Notwithstanding any provision herein to the
contrary, the repricing of Options or SARs is prohibited without prior approval of the Stockholders. For this purpose, a &ldquo;repricing&rdquo;
means any of the following (or any other action that has the same effect as any of the following): (i) changing the terms or conditions
of an Option or SAR to lower its Option Price or SAR Exercise Price; (ii) any other action that is treated as a &ldquo;repricing&rdquo;
under generally accepted accounting principles; and (iii) repurchasing for cash or canceling an Option or SAR at a time when its
Option Price or SAR Exercise Price is greater than the Fair Market Value of the underlying Shares in exchange for another Award,
unless the cancellation and exchange occurs in connection with a change in capitalization or similar change under <B>Section&nbsp;15</B>.
A cancellation and exchange under clause (iii) would be considered a &ldquo;repricing&rdquo; regardless of whether it is treated
as a &ldquo;repricing&rdquo; under generally accepted accounting principles and regardless of whether it is voluntary on the part
of the Participant.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.</TD><TD STYLE="text-align: justify">STOCK SUBJECT TO THE PLAN</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">4.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Authorized Number of Shares</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Subject to adjustment under <B>Section&nbsp;15</B>,
the total number of Shares authorized to be awarded under the Plan shall not exceed 4,600,000 shares. The grant of any full value
Award (i.e., an Award other than an Option or a SAR) shall be deemed, for purposes of determining the number of Shares available
for issuance under this <B>Section 4.1</B>, as an Award of two (2) Shares for each Share actually subject to the Award. The grant
of an Option or SAR shall be deemed, for purposes of determining the number of Shares available for issuance under this <B>Section
4.1</B>, as an Award for one (1) Share for each such Share actually subject to the Award. Any Shares returned to the Plan pursuant
to <B>Section 4.2</B> shall be returned to the reserved pool of Shares under the Plan in the same manner. In addition, Shares underlying
any outstanding award granted under a Prior Plan that, following the Effective Date, expires, or is terminated, surrendered or
forfeited for any reason without issuance of Shares shall be available for the grant of new Awards. As provided in <B>Section&nbsp;1</B>,
no new awards shall be granted under the Prior Plan following the Effective Date. Shares issued under the Plan may consist in whole
or in part of authorized but unissued Shares, treasury Shares or Shares purchased on the open market or otherwise.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">4.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Share Counting</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">4.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT STYLE="font-weight: normal">Any Award settled in cash shall not be counted as issued Shares for any purpose under the Plan.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">4.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT STYLE="font-weight: normal">If any Award expires, or is terminated, surrendered or forfeited, in whole or in part, the unissued
Shares covered by such Award shall again be available for the grant of Awards.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">4.2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT STYLE="font-weight: normal">If Shares issued pursuant to the Plan are repurchased by, or are surrendered or forfeited to
the Company at no more than cost, such Shares shall again be available for the grant of Awards.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">4.2.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT STYLE="font-weight: normal">If Shares issuable upon exercise, vesting or settlement of an Award, or Shares owned by a Participant
(which are not subject to any pledge or other security interest), are surrendered or tendered to the Company in payment of the
Option Price or Purchase Price of an Award or any taxes required to be withheld in respect of an Award, in each case, in accordance
with the terms of the Plan and any applicable Award Agreement, such surrendered or tendered Shares shall not be available again
for the grant of Awards.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">4.2.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<FONT STYLE="font-weight: normal">Substitute Awards shall not be counted against the number of Shares available for the grant of
Awards.</FONT></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">4.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Award Limits</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">4.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Incentive Stock Options</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Subject to adjustment under <B>Section&nbsp;15</B>,
4,600,000 Shares available for issuance under the Plan shall be available for issuance as Incentive Stock Options.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">4.3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Individual Award Limits for Section 162(m) -- Share-Based Awards</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Subject to adjustment under <B>Section 15</B>,
the maximum number of each type of Award (other than cash-based Performance Awards) granted to any Participant in any calendar
year shall not exceed the following number of Shares: (i) Options and SARs: 400,000 Shares; and (ii) all share-based Performance
Awards (including Restricted Stock, RSUs and Other Share-based Awards that are Performance Awards): 400,000 Shares.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">4.3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Individual Award Limits for Section 162(m) -- Cash-Based Awards</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The maximum amount of cash-based Performance Awards
intended to qualify as Performance-Based Compensation granted to any Participant in any calendar year shall not exceed the following:
(i) Annual Incentive Awards: $1,000,000; and (ii) all other cash-based Performance Awards: $1.000,000.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">4.3.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Director Awards</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The maximum value of Awards granted during any
calendar year to any Non-employee Director, taken together with any cash fees paid to such Non-employee Director during the calendar
year and the value of awards granted to the Non-employee Director under any other equity compensation plan of the Company or an
Affiliate during the calendar year, shall not exceed the following in total value (calculating the value of any Awards or other
equity compensation plan awards based on the fair market value as of grant date for financial reporting purposes): (i) $500,000
for the non-employee Chair or Lead Director of the Board and (ii) $425,000 for each Non-employee Director other than the Chair
or Lead Director of the Board; <I>provided, however</I>, that awards granted to Non-employee Directors upon their initial election
to the Board or the board of directors of an Affiliate shall not be counted towards the limit under this <B>Section 4.3.4</B>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.</TD><TD STYLE="text-align: justify">EFFECTIVE DATE, DURATION AND AMENDMENTS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Term</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Plan shall be effective as of the Effective
Date, <I>provided</I> that it has been approved by the Stockholders. The Plan shall terminate automatically on the 10-year anniversary
of the Effective Date and may be terminated on any earlier date as provided in <B>Section&nbsp;5.2</B>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">5.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Amendment and Termination of the Plan</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Board may, at any time and from time to
time, amend, suspend or terminate the Plan as to any Awards which have not been made. An amendment shall be contingent on approval
of the Stockholders to the extent stated by the Board, required by applicable law or required by applicable securities exchange
listing requirements. No Awards shall be made after the Termination Date. The applicable terms of the Plan, and any terms applicable
to Awards granted prior to the Termination Date, shall survive the termination of the Plan and continue to apply to such Awards.
No amendment, suspension or termination of the Plan shall, without the consent of the Participant, materially impair rights or
obligations under any Award theretofore awarded.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.</TD><TD STYLE="text-align: justify">AWARD ELIGIBILITY AND LIMITATIONS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Service Providers</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Subject to this <B>Section&nbsp;6</B>, Awards
may be made to any Service Provider as the Board may determine and designate from time to time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Successive Awards</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">An eligible person may receive more than one
Award, subject to such restrictions as are provided herein.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">6.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Stand-Alone, Additional, Tandem, and Substitute Awards</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Awards may be granted either alone or in addition
to, in tandem with, or in substitution or exchange for, any other Award or any award granted under another plan of the Company,
any Affiliate or any business entity to be acquired by the Company or an Affiliate, or any other right of a Participant to receive
payment from the Company or any Affiliate. Such additional, tandem or substitute or exchange Awards may be granted at any time.
If an Award is granted in substitution or exchange for another award, the Board shall have the right to require the surrender of
such other award in consideration for the grant of the new Award. Subject to the requirements of applicable law, the Board may
make Awards in substitution or exchange for any other award under another plan of the Company, any Affiliate or any business entity
to be acquired by the Company or an Affiliate. In addition, Awards may be granted in lieu of cash compensation, including in lieu
of cash amounts payable under other plans of the Company or any Affiliate, in which the value of Shares subject to the Award is
equivalent in value to the cash compensation (for example, RSUs or Restricted Stock).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0">6.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Minimum Vesting</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Notwithstanding any other provision of the Plan
to the contrary, Share-based Awards granted under the Plan shall vest no earlier than the first anniversary of the date the Award
is granted, excluding, for this purpose, any (i) Substitute Awards, (ii) Shares delivered in lieu of fully vested cash Awards,
and (iii) Awards to Non-employee Directors that vest on the earlier of the one year anniversary of the date of grant or the next
annual meeting of stockholders (provided that such vesting period under this clause (iii) may not be less than 50 weeks after grant;
provided, that, the Board may grant Share-based Awards without regard to the foregoing minimum vesting requirement with respect
to a maximum of five percent (5%) of the available share reserve authorized for issuance under the Plan pursuant to Section 4.1
(subject to adjustment under Section 15); and, provided further, for the avoidance of doubt, that the foregoing restriction does
not apply to the Committee&rsquo;s discretion to provide for accelerated exercisability or vesting of any Award, including in cases
of retirement, death, disability or a Change in Control, in the terms of the Award or otherwise.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.</TD><TD STYLE="text-align: justify">AWARD AGREEMENT</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The grant of any Award may be contingent upon
the Participant executing an appropriate Award Agreement, in such form or forms as the Board shall from time to time determine.
Without limiting the foregoing, an Award Agreement may be provided in the form of a notice which provides that acceptance of the
Award constitutes acceptance of all terms of the Plan and the notice. Award Agreements granted from time to time or at the same
time need not contain similar provisions but shall be consistent with the terms of the Plan. Each Award Agreement evidencing an
Award of Options shall specify whether such Options are intended to be Nonqualified Stock Options or Incentive Stock Options, and
in the absence of such specification such options shall be deemed Nonqualified Stock Options.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.</TD><TD STYLE="text-align: justify">TERMS AND CONDITIONS OF OPTIONS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">8.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Option Price</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Option Price of each Option shall be fixed
by the Board and stated in the related Award Agreement. The Option Price of each Option (except those that constitute Substitute
Awards) shall be at least the Fair Market Value on the Grant Date; <I>provided</I>, <I>however</I>, that in the event that a Participant
is a Ten Percent Stockholder as of the Grant Date, the Option Price of an Option granted to such Participant that is intended to
be an Incentive Stock Option shall be not less than 110 percent of the Fair Market Value on the Grant Date. In no case shall the
Option Price of any Option be less than the par value of a Share.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">8.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Vesting</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Subject to <B>Section&nbsp;8.3</B>, each Option
shall become exercisable at such times and under such conditions (including performance requirements) as stated in the Award Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">8.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Term</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Each Option shall terminate, and all rights
to purchase Shares thereunder shall cease, upon the expiration of the Option term stated in the Award Agreement not to exceed 10
years from the Grant Date, or under such circumstances and on such date prior thereto as is set forth in the Plan or as may be
fixed by the Board and stated in the related Award Agreement; <I>provided</I>, <I>however</I>, that in the event that the Participant
is a Ten Percent Stockholder, an Option granted to such Participant that is intended to be an Incentive Stock Option at the Grant
Date shall not be exercisable after the expiration of five years from its Grant Date.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">8.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Limitations on Exercise of Option</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Notwithstanding any other provision of the Plan,
in no event may any Option be exercised, in whole or in part, (i)&nbsp;prior to the date the Plan is approved by the Stockholders
as provided herein or (ii)&nbsp;after the occurrence of an event which results in termination of the Option.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">8.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Method of Exercise</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">An Option that is exercisable may be exercised
by the Participant&rsquo;s delivery of a notice of exercise to the Company, setting forth the number of Shares with respect to
which the Option is to be exercised, accompanied by full payment for the Shares. To be effective, notice of exercise must be made
in accordance with procedures established by the Company from time to time.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">8.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Rights of Holders of Options</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Unless otherwise provided in the applicable
Award Agreement, an individual holding or exercising an Option shall have none of the rights of a Stockholder (for example, the
right to direct the voting of the subject Shares) until the Shares covered thereby are fully paid and issued to him or her. An
individual holding an Option shall not have the right to receive cash or dividend payments or distributions attributable to the
subject Shares until the Option has been exercised and the Shares covered thereby are fully paid and issued to him or her. Except
as provided in <B>Section&nbsp;15</B> or the related Award Agreement, no adjustment shall be made for dividends, distributions
or other rights for which the record date is prior to the date of such issuance.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">8.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Delivery of Stock Certificates</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Subject to <B>Section&nbsp;3.5</B>, promptly
after the exercise of an Option by a Participant and the payment in full of the Option Price, such Participant shall be entitled
to the issuance of a stock certificate which evidences, or electronic notice of a book entry which records, his or her ownership
of the Shares subject to the Option.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">8.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Limitations on Incentive Stock Options</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">An Option shall constitute an Incentive Stock
Option only (i)&nbsp;if the Participant of such Option is an employee of the Company or any Subsidiary of the Company; (ii)&nbsp;to
the extent specifically provided in the related Award Agreement; and (iii)&nbsp;to the extent that the aggregate Fair Market Value
(determined at the time the Option is granted) of the Shares with respect to which all Incentive Stock Options held by such Participant
become exercisable for the first time during any calendar year (under the Plan and all other plans of the Participant&rsquo;s employer
and its Affiliates) does not exceed $100,000. This limitation shall be applied by taking Options into account in the order in which
they were granted. No Option shall be treated as an Incentive Stock Option unless the Plan has been approved by the Stockholders
in a manner intended to comply with the stockholder approval requirements of Code Section 422(b)(1); <I>provided</I>, <I>however,
</I>that any Option intended to be an Incentive Stock Option shall not fail to be effective solely on account of a failure to obtain
such approval, but rather such Option shall be treated as a Nonqualified Stock Option unless and until such stockholder approval
is obtained.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify">TERMS AND CONDITIONS OF STOCK APPRECIATION RIGHTS (SAR<FONT STYLE="text-transform: none">s)</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">9.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Right to Payment</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">A SAR shall confer on the Participant a right
to receive, upon exercise thereof, the excess of (i)&nbsp;the Fair Market Value on the date of exercise over (ii)&nbsp;the SAR
Exercise Price, as determined by the Board. The Award Agreement for a SAR (except those that constitute Substitute Awards) shall
specify the SAR Exercise Price, which shall be fixed on the Grant Date as not less than the Fair Market Value on that date. SARs
may be granted alone or in conjunction with all or part of an Option or at any subsequent time during the term of such Option or
in conjunction with all or part of any other Award. A SAR granted in tandem with an outstanding Option following the Grant Date
of such Option shall have a grant price that is equal to the Option Price; <I>provided</I>, <I>however</I>, that the SAR&rsquo;s
grant price may not be less than the Fair Market Value on the Grant Date of the SAR to the extent required by Section&nbsp;409A.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">9.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Other Terms</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Board shall determine at the Grant Date
or thereafter, the time or times at which and the circumstances under which a SAR may be exercised in whole or in part (including
based on achievement of performance goals or future service requirements), the time or times at which SARs shall cease to be or
become exercisable following Separation from Service or upon other conditions, the method of exercise, whether or not a SAR shall
be in tandem or in combination with any other Award and any other terms of any SAR.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">9.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Term of SARs</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The term of a SAR granted under the Plan shall
be determined by the Board; <I>provided</I>, <I>however</I>, that such term shall not exceed 10 years.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">9.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Payment of SAR Amount</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Upon exercise of a SAR, a Participant shall
be entitled to receive payment from the Company (in cash or Shares, as set forth in the Award Agreement) in an amount determined
by multiplying:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the difference between the Fair Market Value on the date of exercise over the SAR Exercise Price;
by</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">the number of Shares with respect to which the SAR is exercised.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.</TD><TD STYLE="text-align: justify">TERMS AND CONDITIONS OF RESTRICTED STOCK AND RESTRICTED STOCK UNITS (RSU<FONT STYLE="text-transform: none">s)</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">10.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Restrictions (applicable to Restricted Stock and RSUs)</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">At the time of grant, the Board may establish
a period of time (a &ldquo;<B>Service Period</B>&rdquo;) and any additional restrictions including the satisfaction of corporate
or individual performance objectives applicable to an Award of Restricted Stock or RSUs. Each Award of Restricted Stock or RSUs
may be subject to a different Service Period and additional restrictions. Neither Restricted Stock nor RSUs may be sold, transferred,
assigned, pledged or otherwise encumbered or disposed of during the Service Period or prior to the satisfaction of any other applicable
restrictions.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">10.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Delivery of Shares (applicable to Restricted Stock and RSUs)</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Subject to <B>Section&nbsp;3.5</B>, upon the
expiration or termination of any Service Period and the satisfaction of any other conditions prescribed by the Board, the restrictions
applicable to Shares of Restricted Stock or RSUs settled in Shares shall lapse, and, unless otherwise provided in the applicable
Award Agreement, a stock certificate for such Shares shall be delivered, free of all such restrictions, to the Participant or the
Participant&rsquo;s beneficiary or estate, as the case may be.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">10.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Rights of Holders of Restricted Stock (applicable to Restricted Stock, not RSUs)</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Unless otherwise provided in the applicable
Award Agreement, holders of Restricted Stock shall have rights as Stockholders, including voting and dividend rights; <I>provided</I>,
<I>however</I>, any dividends with respect to the Restricted Stock shall be withheld by the Company for the Participant&rsquo;s
account, and interest may be credited on the amount of the dividends withheld at a rate and subject to such terms as determined
by the Committee. The dividends so withheld by the Committee and attributable to any particular share of Restricted Stock (and
earnings thereon, if applicable) shall be distributed to the Participant in cash or, at the discretion of the Committee, in Shares
having a Fair Market Value equal to the amount of such dividends, if applicable, upon the release of restrictions on such Share
and, if such Share is forfeited, the Participant shall have no right to such dividends.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0">10.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Purchase of Restricted Stock (applicable to Restricted Stock, not RSUs)</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Participant shall be required, to the extent
required by applicable law, to purchase the Restricted Stock from the Company at a Purchase Price equal to the greater of (i)&nbsp;the
aggregate par value of the Shares represented by such Restricted Stock or (ii)&nbsp;the Purchase Price, if any, specified in the
related Award Agreement. If specified in the Award Agreement, the Purchase Price may be deemed paid by services already rendered.
The Purchase Price shall be payable in a form described in <B>Section&nbsp;11</B> or, if so determined by the Board, in consideration
for past services rendered.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">10.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Restricted Stock Certificates (applicable to Restricted Stock, not RSUs)</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Subject to <B>Section&nbsp;3.5</B>, the Company
shall issue, in the name of each Participant to whom Restricted Stock has been granted, stock certificates or other evidence of
ownership representing the total number of Shares of Restricted Stock granted to the Participant, as soon as reasonably practicable
after the Grant Date. The Board may provide in an Award Agreement that either (i)&nbsp;the Secretary of the Company shall hold
any stock certificates for the Participant&rsquo;s benefit until such time as the Restricted Stock is forfeited to the Company
or the restrictions lapse or (ii)&nbsp;such certificates shall be delivered to the Participant; <I>provided</I>, <I>however</I>,
that such certificates shall bear a legend or legends that comply with the applicable securities laws and regulations and make
appropriate reference to the restrictions imposed under the Plan and the Award Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">10.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Rights of Holders of RSUs (applicable to RSUs, not Restricted Stock)</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">10.6.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Settlement of RSUs</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">RSUs may be settled in cash or Shares, as set
forth in the Award Agreement. The Award Agreement shall also set forth whether the RSUs shall be settled (i)&nbsp;within the time
period specified in Section 409A for short term deferrals or (ii)&nbsp;otherwise within the requirements of Section&nbsp;409A,
in which case the Award Agreement shall specify upon which events such RSUs shall be settled.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">10.6.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Voting and Dividend Rights</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Unless otherwise provided in the applicable Award
Agreement, holders of RSUs shall not have rights as Stockholders, including voting or dividend or dividend equivalents rights.
Dividend equivalent rights may be granted with respect to RSUs pursuant to <B>Section 17.10</B>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">10.6.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Creditor&rsquo;s Rights</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">A holder of RSUs shall have no rights other than
those of a general creditor of the Company. RSUs represent an unfunded and unsecured obligation of the Company, subject to the
terms of the applicable Award Agreement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.</TD><TD STYLE="text-align: justify">FORM OF PAYMENT FOR OPTIONS AND RESTRICTED STOCK</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
General Rule</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Payment of the Option Price for the Shares purchased
pursuant to the exercise of an Option or the Purchase Price for Restricted Stock shall be made in cash or in cash equivalents acceptable
to the Company, except as provided in this <B>Section&nbsp;11</B>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Surrender of Shares</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">To the extent the Award Agreement so provides,
payment of the Option Price for Shares purchased pursuant to the exercise of an Option or the Purchase Price for Restricted Stock
may be made all or in part through the tender to the Company of Shares, which Shares shall be valued, for purposes of determining
the extent to which the Option Price or Purchase Price for Restricted Stock has been paid thereby, at their Fair Market Value on
the date of exercise or surrender. Notwithstanding the foregoing, in the case of an Incentive Stock Option, the right to make payment
in the form of already-owned Shares may be authorized only at the time of grant.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Cashless Exercise</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">With respect to an Option only (and not with
respect to Restricted Stock), to the extent permitted by law and to the extent the Award Agreement so provides, payment of the
Option Price may be made all or in part by delivery (on a form acceptable to the Company) of an irrevocable direction to a licensed
securities broker acceptable to the Company to sell Shares and to deliver all or part of the sales proceeds to the Company in payment
of the Option Price and any withholding taxes described in <B>Section&nbsp;17.3</B>.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">11.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Other Forms of Payment</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">To the extent the Award Agreement so provides,
payment of the Option Price or the Purchase Price for Restricted Stock may be made in any other form that is consistent with applicable
laws, regulations and rules, including the Company&rsquo;s withholding of Shares otherwise due to the exercising Participant.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.</TD><TD STYLE="text-align: justify">TERMS AND CONDITIONS OF PERFORMANCE AWARDS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">12.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Performance Conditions</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The right of a Participant to exercise or receive
a grant or settlement of any Award, and the timing thereof, may be subject to such performance conditions as may be specified by
the Board. The Board may use such business criteria and other measures of performance as it may deem appropriate in establishing
any performance conditions, and may reduce the amounts payable under any Award subject to performance conditions, except as limited
under <B>Section 12.2 </B>in the case of Performance-Based Compensation.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">12.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Performance Awards Granted to Designated Covered Employees</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">If and to the extent that the Board determines
that a Performance Award to be granted to a Participant who is designated by the Board as likely to be a Covered Employee should
qualify as Performance-Based Compensation, the grant, exercise or settlement of such Performance Award shall be contingent upon
achievement of pre-established performance goals and other terms set forth in this <B>Section&nbsp;12.2</B>. Notwithstanding anything
herein to the contrary, the Board may provide for Performance Awards to Covered Employees that are not intended to qualify as Performance-Based
Compensation.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><B>12.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Performance
Goals Generally</B></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">The performance goals for Performance Awards shall
consist of one or more business criteria and a targeted level or levels of performance with respect to each of such criteria, as
specified by the Board consistent with this <B>Section&nbsp;12.2</B>. Performance goals shall be objective and shall otherwise
meet the requirements of Section&nbsp;162(m), including the requirement that the level or levels of performance targeted by the
Board result in the achievement of performance goals being &ldquo;substantially uncertain.&rdquo; The Board may determine that
Performance Awards shall be granted, exercised or settled upon achievement of any one performance goal or that two or more of the
performance goals must be achieved as a condition to grant, exercise or settlement of the Performance Awards. Performance goals
may be established on a Company-wide basis, or with respect to one or more business units, divisions, Affiliates or business segments,
as applicable. To the extent consistent with the requirements of Section&nbsp;162(m), the Committee may determine at the time that
goals under this <B>Section&nbsp;12 </B>are established the extent to which measurement of performance goals may exclude the impact
of charges for restructuring, discontinued operations, extraordinary items, debt redemption or retirement, asset write downs, litigation
or claim judgments or settlements, acquisitions or divestitures, foreign exchange gains and losses and other extraordinary, unusual
or non-recurring items, and the cumulative effects of tax or accounting changes (each as defined by generally accepted accounting
principles and as identified in the Company&rsquo;s financial statements or other SEC filings). Performance goals may differ for
Performance Awards granted to any one Participant or to different Participants.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><B>12.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Business
Criteria</B></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">One or more of the following business criteria
for the Company, on a consolidated basis, or specified Affiliates or business units of the Company (except with respect to the
total stockholder return and earnings per share criteria), shall be used exclusively by the Board in establishing performance goals
for Performance Awards: (i) cash flow; (ii) earnings per share, as adjusted for any stock split, stock dividend or other recapitalization;
(iii) earnings measures; (iv) return on equity; (v) total stockholder return; (vi) share price performance, as adjusted for any
stock split, stock dividend or other recapitalization; (vii) return on capital; (viii) revenue; (ix) income; (x) profit margin;
(xi) return on operating revenue; (xii) brand recognition or acceptance; (xiii) customer satisfaction; (xiv) productivity; (xv)
expense targets; (xvi) market share; (xvii) cost control measures; (xviii) balance sheet metrics; (xix) strategic initiatives;
(xx) implementation, completion or attainment of measurable objectives with respect to recruitment or retention of personnel or
employee satisfaction; (xxi) regulatory body approval for commercialization of a product; (xxii) implementation or completion of
critical projects; or (xxiii) any other business criteria established by the Board; <I>provided</I>, <I>however</I>, that such
business criteria shall include any derivations of business criteria listed above (<I>e.g.</I>, income shall include pre-tax income,
net income and operating income).</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><B>12.2.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Timing
for Establishing Performance Goals</B></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Performance goals shall be established not later
than 90 days after the beginning of any performance period applicable to Performance Awards, or at such other date as may be required
or permitted for Performance-Based Compensation.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><B>12.2.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Settlement
of Performance Awards; Other Terms</B></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Settlement of Performance Awards may be in cash,
Shares, other Awards or other property. The Board may reduce the amount of a settlement otherwise to be made in connection with
such Performance Awards.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">12.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Written Determinations</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">All determinations by the Board as to the establishment
of performance goals, the amount of any Performance Award pool or potential individual Performance Awards and the achievement of
performance goals relating to Performance Awards, shall be made in writing in the case of any Award intended to qualify as Performance-Based
Compensation to the extent required by Section&nbsp;162(m). To the extent permitted by Section&nbsp;162(m), the Board may delegate
any responsibility relating to Performance Awards.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">12.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Status of Section&nbsp;12.2 Awards under Section&nbsp;162(m)</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">It is the intent of the Company that Performance
Awards under <B>Section&nbsp;12.2</B> granted to persons who are designated by the Board as likely to be Covered Employees within
the meaning of Section&nbsp;162(m) shall, if so designated by the Board, qualify as Performance-Based Compensation. Accordingly,
the terms of <B>Section&nbsp;12.2</B>, including the definitions of Covered Employee and other terms used therein, shall be interpreted
in a manner consistent with Section&nbsp;162(m). The foregoing notwithstanding, because the Board cannot determine with certainty
whether a given Participant will be a Covered Employee with respect to a fiscal year that has not yet been completed, the term
Covered Employee as used herein shall mean only a person designated by the Board, at the time of grant of Performance Awards, as
likely to be a Covered Employee with respect to that fiscal year. If any provision of the Plan or any agreement relating to such
Performance Awards does not comply or is inconsistent with the requirements of Section&nbsp;162(m), such provision shall be construed
or deemed amended to the extent necessary to conform to such requirements.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.</TD><TD STYLE="text-align: justify">other SHARE-based awards</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">13.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Grant of Other Share-based Awards</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Other Share-based Awards may be granted either
alone or in addition to or in conjunction with other Awards. Other Share-based Awards may be granted in lieu of other cash or other
compensation to which a Service Provider is entitled from the Company or may be used in the settlement of amounts payable in Shares
under any other compensation plan or arrangement of the Company, including any other Company incentive compensation plan. The Board
shall have the authority to determine the persons to whom and the time or times at which such Awards will be made, the number of
Shares to be granted pursuant to such Awards, and all other terms of such Awards. Unless the Board determines otherwise, any such
Award shall be confirmed by an Award Agreement, which shall contain such provisions as the Board determines to be necessary or
appropriate to carry out the intent of the Plan with respect to such Award.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">13.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Terms of Other Share-based Awards</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Any Common Stock subject to Awards made under
this <B>Section&nbsp;13</B> may not be sold, assigned, transferred, pledged or otherwise encumbered prior to the date on which
the Shares are issued, or, if later, the date on which any applicable restriction, performance or deferral period lapses.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.</TD><TD STYLE="text-align: justify">REQUIREMENTS OF LAW</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">14.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
General</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Company shall not be required to sell or
issue any Shares under any Award if the sale or issuance of such Shares would constitute a violation by the Participant, any other
individual exercising an Option or the Company of any provision of any law or regulation of any governmental authority, including
any federal or state securities laws or regulations. If at any time the Board determines that the listing, registration or qualification
of any Shares subject to an Award upon any securities exchange or under any governmental regulatory body is necessary or desirable
as a condition of, or in connection with, the issuance or purchase of Shares hereunder, no Shares may be issued or sold to the
Participant or any other individual exercising an Option pursuant to such Award unless such listing, registration, qualification,
consent or approval shall have been effected or obtained free of any conditions not acceptable to the Company, and any delay caused
thereby shall in no way affect the date of termination of the Award. Specifically, in connection with the Securities Act, upon
the exercise of any Option or the delivery of any Shares underlying an Award, unless a registration statement under such Act is
in effect with respect to the Shares covered by such Award, the Company shall not be required to sell or issue such Shares unless
the Board has received evidence satisfactory to it that the Participant or any other individual exercising an Option may acquire
such Shares pursuant to an exemption from registration under the Securities Act. The Company may, but shall in no event be obligated
to, register any securities covered hereby pursuant to the Securities Act. The Company shall not be obligated to take any affirmative
action in order to cause the exercise of an Option or the issuance of Shares pursuant to the Plan to comply with any law or regulation
of any governmental authority. As to any jurisdiction that expressly imposes the requirement that an Option shall not be exercisable
until the Shares covered by such Option are registered or are exempt from registration, the exercise of such Option (under circumstances
in which the laws of such jurisdiction apply) shall be deemed conditioned upon the effectiveness of such registration or the availability
of such an exemption. The Committee may require the Participant to sign such additional documentation, make such representations
and furnish such information as it may consider appropriate in connection with the grant of Awards or issuance or delivery of Shares
in compliance with applicable laws, rules and regulations.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">14.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Rule 16b-3</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">During any time when the Company has a class
of equity security registered under Section&nbsp;12 of the Exchange Act, it is the intent of the Company that Awards and the exercise
of Options will qualify for the exemption provided by Rule 16b-3 under the Exchange Act. To the extent that any provision of the
Plan or action by the Board or Committee does not comply with the requirements of Rule 16b-3, it shall be deemed inoperative to
the extent permitted by law and deemed advisable by the Board, and shall not affect the validity of the Plan. In the event that
Rule 16b-3 is revised or replaced, the Board may modify the Plan in any respect necessary to satisfy the requirements of, or to
take advantage of any features of, the revised exemption or its replacement.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.</TD><TD STYLE="text-align: justify">EFFECT OF CHANGES IN CAPITALIZATION</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">15.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Adjustments for Changes in Capital Structure</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Subject to any required action by the Stockholders,
in the event of any change in the Common Stock effected without receipt of consideration by the Company, whether through merger,
consolidation, reorganization, reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock
split, split-up, split-off, spin-off, combination of shares, exchange of shares or similar change in the capital structure of the
Company, or in the event of payment of a dividend or distribution to the Stockholders in a form other than Shares (excepting normal
cash dividends) that has a material effect on the Fair Market Value, appropriate and proportionate adjustments shall be made in
the number and class of shares subject to the Plan and to any outstanding Awards, and in the Option Price, SAR Exercise Price or
Purchase Price per Share of any outstanding Awards in order to prevent dilution or enlargement of Participants&rsquo; rights under
the Plan. For purposes of the foregoing, conversion of any convertible securities of the Company shall not be treated as &ldquo;effected
without receipt of consideration by the Company.&rdquo; If a majority of the Shares which are of the same class as the Shares that
are subject to outstanding Awards are exchanged for, converted into, or otherwise become (whether or not pursuant to a Change in
Control) shares of another corporation (the &ldquo;<B>New Shares</B>&rdquo;), the Board may unilaterally amend the outstanding
Awards to provide that such Awards are for New Shares. In the event of any such amendment, the number of Shares subject to, and
the Option Price, SAR Exercise Price or Purchase Price per Share of, the outstanding Awards shall be adjusted in a fair and equitable
manner. Any fractional share resulting from an adjustment pursuant to this <B>Section 15.1 </B>shall be rounded down to the nearest
whole number and the Option Price, SAR Exercise Price or Purchase Price per share shall be rounded up to the nearest whole cent.
In no event may the exercise price of any Award be decreased to an amount less than the par value, if any, of the stock subject
to the Award. The Board may also make such adjustments in the terms of any Award to reflect, or related to, such changes in the
capital structure of the Company or distributions as it deems appropriate. Adjustments determined by the Board pursuant to this
<B>Section 15.1</B> shall be made in accordance with Section 409A to the extent applicable.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">15.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Change in Control</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><B>15.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Consequences
of a Change in Control</B></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Subject to the requirements and limitations of
Section 409A if applicable, the Board may provide for any one or more of the following in connection with a Change in Control,
which such actions need not be the same for all Participants:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B>Accelerated Vesting</B>. The Board may provide in any Award Agreement, or in the event of a Change in Control may take such
actions as it deems appropriate to provide, for the acceleration of the exercisability, vesting or settlement in connection with
such Change in Control of each or any outstanding Award or portion thereof and Shares acquired pursuant thereto upon such terms,
including a Participant&rsquo;s Separation from Service prior to, upon, or following such Change in Control, to such extent as
determined by the Board.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B>Assumption, Continuation or Substitution</B>. In the event of a Change in Control, the surviving, continuing, successor or purchasing
corporation or other business entity or parent thereof, as the case may be (the &ldquo;<B>Acquiror</B>&rdquo;), may, without the
consent of any Participant, either assume or continue the Company&rsquo;s rights and obligations under each or any Award or portion
thereof outstanding immediately prior to the Change in Control or substitute for each or any such outstanding Award or portion
thereof a substantially equivalent award with respect to the Acquiror&rsquo;s stock, as applicable. For purposes of this <B>Section
15.2.1</B>, an Award denominated in Shares shall be deemed assumed if, following the Change in Control, the Award confers the right
to receive, subject to the terms of the Plan and the applicable Award Agreement, for each Share subject to the Award immediately
prior to the Change in Control, the consideration (whether stock, cash, other securities or property or a combination thereof)
to which a Stockholder on the effective date of the Change in Control was entitled; <I>provided, however</I>, that if such consideration
is not solely common stock of the Acquiror, the Board may, with the consent of the Acquiror, provide for the consideration to be
received upon the exercise or settlement of the Award, for each Share subject to the Award, to consist solely of common stock of
the Acquiror equal in Fair Market Value to the per Share consideration received by Stockholders pursuant to the Change in Control.
If any portion of such consideration may be received by Stockholders pursuant to the Change in Control on a contingent or delayed
basis, the Board may determine such Fair Market Value as of the time of the Change in Control on the basis of the Board&rsquo;s
estimate of the present value of the probable future payment of such consideration. Any Award or portion thereof which is neither
assumed or continued by the Acquiror in connection with the Change in Control nor exercised or settled as of the time of consummation
of the Change in Control shall terminate and cease to be outstanding effective as of the time of consummation of the Change in
Control.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<B>Cash-Out of Awards.</B> The Board may, without the consent of any Participant, determine that, upon the occurrence of a Change
in Control, each or any Award or a portion thereof outstanding immediately prior to the Change in Control and not previously exercised
or settled shall be canceled in exchange for a payment with respect to each vested Share (and each unvested Share, if so determined
by the Board) subject to such canceled Award in (i) cash, (ii) stock of the Company or of a corporation or other business entity
a party to the Change in Control or (iii) other property which, in any such case, shall be in an amount having a Fair Market Value
equal to the Fair Market Value of the consideration to be paid per Share in the Change in Control, reduced by the exercise or purchase
price per Share, if any, under such Award. If any portion of such consideration may be received by Stockholders pursuant to the
Change in Control on a contingent or delayed basis, the Board may determine such Fair Market Value as of the time of the Change
in Control on the basis of the Board&rsquo;s estimate of the present value of the probable future payment of such consideration.
In the event such determination is made by the Board, the amount of such payment (reduced by applicable withholding taxes, if any)
shall be paid to Participants in respect of the vested portions of their canceled Awards as soon as practicable following the date
of the Change in Control and in respect of the unvested portions of their canceled Awards in accordance with the vesting schedules
applicable to such Awards. For avoidance of doubt, if the amount determined pursuant to this <B>Section 15.2.1(c) </B>for an Option
or SAR is zero or less, the affected Option or SAR may be cancelled without any payment therefore.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><B>15.2.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Change
in Control Defined</B></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Unless otherwise provided in the applicable Award
Agreement, a &ldquo;<B>Change in Control</B>&rdquo; means the consummation of any of the following events:</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
the acquisition, other than from the Company, by any individual, entity or group (within the meaning of Section&nbsp;13(d)(3) or
Section&nbsp;14(d)(2) of the Exchange Act), other than the Company or any subsidiary, affiliate (within the meaning of Rule 144
promulgated under the Securities Act) or employee benefit plan of the Company, of beneficial ownership (within the meaning of Rule
13d-3 promulgated under the Exchange Act) of more than 50% of the combined voting power of the then outstanding voting securities
of the Company entitled to vote generally in the election of directors (the &ldquo;<B>Voting Securities</B>&rdquo;); or</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
a reorganization, merger, consolidation or recapitalization of the Company (a &ldquo;<B>Business Combination</B>&rdquo;), other
than a Business Combination in which more than 50% of the combined voting power of the outstanding voting securities of the surviving
or resulting entity immediately following the Business Combination is held by the persons who, immediately prior to the Business
Combination, were the holders of the Voting Securities; or</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
a complete liquidation or dissolution of the Company, or a sale of all or substantially all of the assets of the Company; or</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
during any period of 12 consecutive months, the Incumbent Directors cease to constitute a majority of the Board; &ldquo;<B>Incumbent
Directors</B>&rdquo; means individuals who were members of the Board at the beginning of such period or individuals whose election
or nomination for election to the Board by the Stockholders was approved by a vote of at least a majority of the then Incumbent
Directors (but excluding any individual whose initial election or nomination is in connection with an actual or threatened proxy
contest relating to the election of directors).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Notwithstanding the foregoing, if it is determined
that an Award is subject to the requirements of Section&nbsp;409A and payable upon a Change in Control, the Company will not be
deemed to have undergone a Change in Control for purposes of the Plan unless the Company is deemed to have undergone a &ldquo;change
in control event&rdquo; pursuant to the definition of such term in Section&nbsp;409A.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">15.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Adjustments</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Adjustments under this <B>Section&nbsp;15</B>
related to Shares or other securities of the Company shall be made by the Board. No fractional Shares or other securities shall
be issued pursuant to any such adjustment, and any fractions resulting from any such adjustment shall be eliminated in each case
by rounding downward to the nearest whole Share.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.</TD><TD STYLE="text-align: justify">No Limitations on Company</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The making of Awards shall not affect or limit
in any way the right or power of the Company to make adjustments, reclassifications, reorganizations or changes of its capital
or business structure or to merge, consolidate, dissolve or liquidate, or to sell or transfer all or any part of its business or
assets.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; font-weight: bold; text-transform: uppercase; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.</TD><TD STYLE="text-align: justify">TERMS APPLICABLE GENERALLY TO AWARDS</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">17.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Disclaimer of Rights</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">No provision in the Plan or in any Award Agreement
shall be construed to confer upon any individual the right to remain in the employ or service of the Company or any Affiliate,
or to interfere in any way with any contractual or other right or authority of the Company or any Affiliate either to increase
or decrease the compensation or other payments to any individual at any time, or to terminate any employment or other relationship
between any individual and the Company or any Affiliate. In addition, notwithstanding anything contained in the Plan to the contrary,
unless otherwise provided in the applicable Award Agreement, no Award shall be affected by any change of duties or position of
the Participant, so long as such Participant continues to be a Service Provider. The obligation of the Company to pay any benefits
pursuant to the Plan shall be interpreted as a contractual obligation to pay only those amounts described herein, in the manner
and under the conditions prescribed herein. The Plan shall in no way be interpreted to require the Company to transfer any amounts
to a third party trustee or otherwise hold any amounts in trust or escrow for payment to any Participant or beneficiary under the
terms of the Plan.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">17.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Nonexclusivity of the Plan</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Neither the adoption of the Plan nor the submission
of the Plan to the Stockholders for approval shall be construed as creating any limitations upon the right or authority of the
Board or its delegate to adopt such other compensation arrangements as the Board or its delegate determines desirable.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">17.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Withholding Taxes</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Company or an Affiliate, as the case may
be, shall have the right to deduct from payments of any kind otherwise due to a Participant any federal, state or local taxes of
any kind required by law to be withheld (i)&nbsp;with respect to the vesting of or other lapse of restrictions applicable to an
Award, (ii)&nbsp;upon the issuance of any Shares upon the exercise of an Option or SAR or (iii)&nbsp;otherwise due in connection
with an Award. At the time of such vesting, lapse or exercise, the Participant shall pay to the Company or the Affiliate, as the
case may be, any amount that the Company or the Affiliate may reasonably determine to be necessary to satisfy such withholding
obligation. In addition, the Board may provide one or more Participants with the right to direct the Company to withhold, from
the Shares otherwise issuable upon the exercise of an Option or Stock Appreciation Right or upon the issuance of fully-vested Shares
(whether pursuant to Restricted Stock, RSUs, Other Share-based Awards, or otherwise), a portion of those Shares with an aggregate
Fair Market Value equal to the percentage of the applicable withholding taxes (not to exceed one hundred percent (100%)) designated
by the Participant;&nbsp;<B><I>provided, however</I></B>, that the amount of any Shares so withheld shall not exceed the amount
necessary to satisfy the Company&rsquo;s required tax withholding obligations using not more than the applicable maximum statutory
withholding rates (or such other rates as required to avoid adverse accounting treatment as determined by the Board). The Fair
Market Value of the Shares used to satisfy such withholding obligation shall be determined by the Company or the Affiliate as of
the date that the amount of tax to be withheld is to be determined. A Participant who has made an election pursuant to this <B>Section&nbsp;17.3</B>
may satisfy his or her withholding obligation only with Shares that are not subject to any repurchase, forfeiture, unfulfilled
vesting or other similar requirements.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">17.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Other Provisions; Legends</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">Each Award Agreement may contain such other
terms not inconsistent with the Plan as may be determined by the Board. Any stock certificates for any Shares issued under the
Plan shall be subject to such stop-transfer orders and other restrictions as the Company in its sole discretion may deem advisable
under the rules, regulations and other requirements of the SEC, any securities exchange on which the Common Stock may then be listed
and any applicable federal or state securities law, and the Company in its sole discretion may cause a legend or legends to be
placed on such certificates to make appropriate reference to such restrictions.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">17.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Severability</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">If any provision of the Plan or any Award Agreement
shall be determined to be illegal or unenforceable by any court of law in any jurisdiction, the remaining provisions hereof and
thereof shall be severable and enforceable in accordance with their terms, and all provisions shall remain enforceable in any other
jurisdiction.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">17.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Governing Law</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Plan shall be governed by and construed
in accordance with the internal laws of the Commonwealth of Massachusetts without regard to the principles of conflicts of law
thereof or principles of conflicts of laws of any other jurisdiction that could cause the application of the laws of any jurisdiction
other than the Commonwealth of Massachusetts. For purposes of resolving any dispute that arises directly or indirectly in connection
with the Plan, each Participant, by virtue of receiving an Award, shall be deemed to have submitted to and consented to the exclusive
jurisdiction of the Commonwealth of Massachusetts and to have agreed that any related litigation shall be conducted solely in the
courts of Middlesex County, Massachusetts or the United States District Court for the District of Massachusetts, where the Plan
is made and to be performed, and no other courts.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">17.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Section&nbsp;409A</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Plan is intended to comply with Section&nbsp;409A,
and, accordingly, to the maximum extent permitted, the Plan shall be interpreted and administered to be in compliance therewith.
Any payments described in the Plan that are due within the &ldquo;short-term deferral period&rdquo; as defined in Section&nbsp;409A
shall not be treated as deferred compensation unless applicable laws require otherwise. Notwithstanding anything to the contrary
in the Plan, to the extent required to avoid accelerated taxation and tax penalties under Section&nbsp;409A, amounts that would
otherwise be payable and benefits that would otherwise be provided pursuant to the Plan during the six-month period immediately
following the Participant&rsquo;s Separation from Service shall instead be paid on the first payroll date after the six-month anniversary
of the Participant&rsquo;s Separation from Service (or the Participant&rsquo;s death, if earlier). Notwithstanding the foregoing,
neither the Company nor the Committee shall have any obligation to take any action to prevent the assessment of any excise tax
or penalty on any Participant under Section&nbsp;409A and neither the Company nor the Board shall have any liability to any Participant
for such tax or penalty.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">17.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Separation from Service</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">The Board shall determine the effect of a Separation
from Service upon Awards, and such effect shall be set forth in the applicable Award Agreement. Without limiting the foregoing,
the Board may provide in the Award Agreements at the time of grant, or any time thereafter with the consent of the Participant,
the actions that will be taken upon the occurrence of a Separation from Service, including accelerated vesting or termination,
depending upon the circumstances surrounding the Separation from Service.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">17.9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Transferability of Awards</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><B>17.9.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Transfers
in General</B></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">Except as provided in <B>Section&nbsp;17.9.2</B>,
no Award shall be assignable or transferable by the Participant to whom it is granted, other than by will or the laws of descent
and distribution, and, during the lifetime of the Participant, only the Participant personally (or the Participant&rsquo;s personal
representative) may exercise rights under the Plan.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 1in"><B>17.9.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Family
Transfers</B></P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 1.7in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">If authorized in the applicable Award Agreement,
a Participant may transfer, not for value, all or part of an Award (other than Incentive Stock Options) to any Family Member. For
the purpose of this <B>Section&nbsp;17.9.2</B>, a &ldquo;not for value&rdquo; transfer is a transfer which is (i)&nbsp;a gift,
(ii)&nbsp;a transfer under a domestic relations order in settlement of marital property rights or (iii)&nbsp;a transfer to an entity
in which more than 50% of the voting interests are owned by Family Members (or the Participant) in exchange for an interest in
that entity. Following a transfer under this <B>Section&nbsp;17.9.2</B>, any such Award shall continue to be subject to the same
terms as were applicable immediately prior to transfer. Subsequent transfers of transferred Awards are prohibited except to Family
Members of the original Participant in accordance with this <B>Section&nbsp;17.9.2</B> or by will or the laws of descent and distribution.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 1in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">17.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Dividends and Dividend Equivalent Rights</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">If specified in the Award Agreement, the recipient
of an Award may be entitled to receive, currently or on a deferred basis, dividends or dividend equivalents with respect to the
Common Stock or other securities covered by an Award; <I>provided</I>, <I>however</I>, that no dividends or dividend equivalents
may be paid or granted with respect to an Option or SAR or the Shares subject thereto until such Award has been exercised. The
terms of a dividend equivalent right may be set forth in the Award Agreement. Dividend equivalents credited to a Participant may
be paid currently or may be deemed to be reinvested in additional Shares or other securities of the Company at a price per unit
equal to the Fair Market Value on the date that such dividend was paid to Stockholders. Notwithstanding the foregoing, in no event
will dividends or dividend equivalents on any Award that is subject to vesting conditions (including the achievement of performance
criteria) be payable before the Award has become vested.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">17.11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Data Protection</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">A Participant&rsquo;s acceptance of an Award
shall be deemed to constitute the Participant&rsquo;s acknowledgement of and consent to the collection and processing of personal
data relating to the Participant so that the Company and the Affiliates can fulfill their obligations and exercise their rights
under the Plan and generally administer and manage the Plan. This data shall include data about participation in the Plan and Shares
offered or received, purchased or sold under the Plan and other appropriate financial and other data (such as the date on which
the Awards were granted) about the Participant and the Participant&rsquo;s participation in the Plan.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">17.12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
Plan Construction</P>

<P STYLE="font-size: 10pt; font-weight: bold; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">In the Plan, unless otherwise stated, the following
uses apply: (i)&nbsp;references to a statute or law refer to the statute or law and any amendments and any successor statutes or
laws, and to all valid and binding governmental regulations, court decisions and other regulatory and judicial authority issued
or rendered thereunder, as amended, or their successors, as in effect at the relevant time; (ii)&nbsp;in computing periods from
a specified date to a later specified date, the words &ldquo;from&rdquo; and &ldquo;commencing on&rdquo; (and the like) mean &ldquo;from
and including,&rdquo; and the words &ldquo;to,&rdquo; &ldquo;until&rdquo; and &ldquo;ending on&rdquo; (and the like) mean &ldquo;to
and including&rdquo;; (iii)&nbsp;indications of time of day shall be based upon the time applicable to the location of the principal
headquarters of the Company; (iv)&nbsp;the words &ldquo;include,&rdquo; &ldquo;includes&rdquo; and &ldquo;including&rdquo; (and
the like) mean &ldquo;include, without limitation,&rdquo; &ldquo;includes, without limitation&rdquo; and &ldquo;including, without
limitation&rdquo; (and the like), respectively; (v)&nbsp;all references to articles and sections are to articles and sections in
the Plan; (vi)&nbsp;all words used shall be construed to be of such gender or number as the circumstances and context require;
(vii)&nbsp;the captions and headings of articles and sections have been inserted solely for convenience of reference and shall
not be considered a part of the Plan, nor shall any of them affect the meaning or interpretation of the Plan or any of its provisions;
(viii)&nbsp;any reference to an agreement, plan, policy, form, document or set of documents, and the rights and obligations of
the parties under any such agreement, plan, policy, form, document or set of documents, shall mean such agreement, plan, policy,
form, document or set of documents as amended from time to time, and any and all modifications, extensions, renewals, substitutions
or replacements thereof; and (ix)&nbsp;all accounting terms not specifically defined shall be construed in accordance with GAAP.</P>

<P STYLE="font-size: 10pt; text-align: justify; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 60%">
<TR>
    <TD STYLE="white-space: nowrap; width: 49%; font-size: 10pt; font-weight: bold; text-align: left; padding-left: 0pt">Adopted by the Board:</TD>
    <TD STYLE="width: 51%; font-size: 10pt; font-weight: bold">March 31, 2017</TD></TR>
<TR>
    <TD STYLE="white-space: nowrap; text-align: left; font-size: 10pt; padding-left: 0pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR>
    <TD STYLE="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left; padding-left: 0pt">Approved by the Stockholders:</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold">June 13, 2017</TD></TR>
<TR>
    <TD STYLE="white-space: nowrap; text-align: left; font-size: 10pt; padding-left: 0pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR>
    <TD STYLE="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left; padding-left: 0pt">Amended by the Stockholders:</TD>
    <TD STYLE="white-space: nowrap; font-size: 10pt; font-weight: bold">June 18, 2019; June 16, 2020; June 16, 2021</TD></TR>
<TR>
    <TD STYLE="white-space: nowrap; text-align: left; font-size: 10pt; padding-left: 0pt">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR>
    <TD STYLE="white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: left; padding-left: 0pt">Scheduled Termination Date:</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold">June 13, 2027</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">20</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>exh_992.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font-size: 10pt; text-align: right; margin: 0pt 0"><B>EXHIBIT 99.2</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font-size: 10pt; font-variant: small-caps; font-weight: bold; text-align: center; margin: 0pt 0">ANIKA THERAPEUTICS,
INC.</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>2021 EMPLOYEE STOCK PURCHASE PLAN</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article 1 - Purpose</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">This 2021 Employee Stock Purchase Plan (the &ldquo;Plan&rdquo;) is
intended to encourage stock ownership by all eligible employees of Anika Therapeutics, Inc., a Delaware corporation (including
any successor corporation, the &ldquo;Company&rdquo;), and its participating subsidiaries (as defined in Article&nbsp;17) so that
they may share in the growth of the Company by acquiring or increasing their proprietary interest in the Company. The Plan is designed
to encourage eligible employees to remain in the employ of the Company and its participating subsidiaries. Except as described
below in Article 2, the Plan is intended to constitute an &ldquo;employee stock purchase plan&rdquo; within the meaning of Section&nbsp;423(b)
of the Internal Revenue Code of&nbsp;1986, as amended (the &ldquo;Code&rdquo;).</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article 2 - Administration of the Plan</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">The Plan will be administered by the Compensation Committee of
the Company&rsquo;s Board of Directors (the &ldquo;Board&rdquo;), or such other committee as determined by the Board (the
&ldquo;Committee&rdquo;).</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">Notwithstanding anything to the contrary in the Plan, the Committee may establish sub-plans (which
need not qualify under section 423 of the Code) and initiate separate Offering Periods (as defined in Article&nbsp;5) through
such sub-plans for the purpose of (i) facilitating participation in the Plan by non-U.S. employees in compliance with foreign
laws and regulations without affecting the qualification of the remainder of the Plan under section 423 of the Code or (ii)
qualifying the Plan for preferred tax treatment under foreign tax laws (which sub-plans, at the Committee&rsquo;s discretion,
may provide for allocations of the authorized shares reserved for issue under the Plan as set forth in Article 4). The rules,
guidelines and forms of such sub-plans (or the Offering Periods thereunder) may take precedence over other provisions of the
Plan, with the exception of the maximum Offering Period term set forth in Article 5, the maximum payroll deduction set forth
in Article 8, the limitation on the decrease to the Option Price defined and described in Article 5 and the aggregate stock
limit described in Article 4, but unless otherwise superseded by the terms of such sub-plan, the provisions of the Plan shall
govern the operation of such sub-plan. Alternatively, notwithstanding anything to the contrary in the Plan, in order to
comply with the laws of a foreign jurisdiction, the Committee shall have the power, in its discretion, to grant options in an
Offering Period to citizens or residents of a non-U.S. jurisdiction (without regard to whether they are also citizens of the
United States or resident aliens) that provide terms which are less favorable than the terms of options granted under the
same Offering Period to employees resident in the United States, subject to compliance with section 423 of the Code.&#9;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">The interpretation and construction by the Committee of any provisions
of the Plan or of any option granted under it will be final, unless otherwise determined by the Board. The Committee may from time
to time adopt such rules and regulations for carrying out the Plan as it may deem best, provided that any such rules and regulations
will be applied on a uniform basis to all employees under the Plan. No member of the Board or the Committee will be liable for
any action or determination made in good faith with respect to the Plan or any option granted under it.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article 3 - Eligible Employees</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">Except as otherwise determined by the Committee with respect to an
Offering Period prior to the start date thereof, all employees of the Company or any of its participating subsidiaries who are
(i) so employed on the start date of any Offering Period and (2) have continuously been employed with the Company or such participating
subsidiary for at least one month prior to such start date will be eligible to participate and receive an option with respect to
such Offering Period. All such eligible employees will have the same rights and privileges hereunder with respect to such Offering
Period. In no event, however, may an employee be granted an option if such employee, immediately after the option is granted, would
be treated as owning stock possessing five&nbsp;percent or more of the total combined voting power or value of all classes of stock
of the Company or of any parent corporation or subsidiary corporation, as the terms &ldquo;parent corporation&rdquo; and &ldquo;subsidiary
corporation&rdquo; are defined in Section&nbsp;424(e) and Section&nbsp;424(f) of the Code. For purposes of determining stock ownership
under this paragraph, the rules of Section&nbsp;424(d) of the Code will apply, and stock which the employee may purchase under
outstanding options (including options not granted under the Plan) will be treated as stock owned by the employee. Notwithstanding
the foregoing, except as otherwise determined by the Committee with respect to an Offering Period prior to the start date thereof,
employees who are otherwise eligible employees and who are citizens or residents of a non-U.S. jurisdiction (without regard to
whether such employee is also a citizen of the United States or a resident alien (within the meaning of Section 7701(b)(1)(A) of
the Code)) will not be considered an eligible employee if his or her participation is prohibited under the laws of the applicable
non-U.S. jurisdiction or if complying with the laws of the applicable non-U.S. jurisdiction would cause the Plan or an Offering
Period to violate Section 423 of the Code.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;4 - Stock Subject to the Plan</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">The stock subject to the options under the Plan will be shares of
the Company&rsquo;s authorized but unissued common stock (the &ldquo;Common Stock&rdquo;), or shares of Common Stock reacquired
by the Company, including shares purchased in the open market. The aggregate number of shares of Common Stock which may be issued
pursuant to the Plan is 200,000, subject to adjustment as provided in Article&nbsp;12. If any option granted under the Plan expires
or terminates for any reason without having been exercised in full or ceases for any reason to be exercisable in whole or in part,
the unpurchased shares subject thereto will again be available under the Plan.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;5 - Offering Period and Stock Options</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Except as otherwise determined by the Committee, the first Offering
Period will start on November 15, 2021 and will end on May 14, 2022, provided that if such end date is not a business day (as defined
below in this Article 5), such Offering Period will end on the first business day preceding such end date.</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Thereafter, except as otherwise determined by the Committee:</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">1.</TD><TD>An offering period (&ldquo;<U>Offering Period</U>&rdquo;) will start on each May 15 (provided that if such start date is not
a business day, such start date will be the first business day following the immediately preceding Exercise Date (as defined below
in this Article 5)) and end on the following November 14 (provided that if such end date is not a business day, such end date will
be the first business day preceding such end date); and</TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0 0pt 0.75in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in">2.</TD><TD>An Offering Period will start on each November 15 (provided that if such start date is not a business day, such start date
will be the first business day following the immediately preceding Exercise Date) and end on the following May 14 (provided that
if such end date is not a business day, such end date will be the first business day preceding such end date).</TD></TR></TABLE>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">The end date within each Offering Period will be the day on which shares of Common Stock
are purchased by participants in an Offering Period (&ldquo;Exercise Date&rdquo;). On the start date of each Offering Period, the
Company will grant to each eligible employee who has then elected to be a participant in the Plan an option to purchase shares
on the relevant Exercise Date, at the Option Price hereinafter provided for, covering a maximum of 800 shares of Common Stock (which
maximum number may be amended by the Committee from time to time with respect to an Offering Period prior to the start date thereof),
on condition that such employee remains an eligible employee through the Exercise Date. If a participant&rsquo;s accumulated payroll
deductions on the end date of an Offering Period would enable the participant to purchase more than such maximum number of shares
of Common Stock, the excess of the amount of the accumulated payroll deductions over the aggregate purchase price of such maximum
number of shares will be promptly refunded to the participant by the Company, without interest. A participant will be entitled
to exercise the option so granted only to the extent of the participant&rsquo;s accumulated payroll deductions on the Exercise
Date. The Option Price per share for each Exercise Date within an Offering Period will be the lesser of (i)&nbsp;85% of the Fair
Market Value of the Common Stock on the start date of the Offering Period and (ii)&nbsp;85% of the Fair Market Value of the Common
Stock on the Exercise Date, in either event rounded up to the nearest cent. Prior to the start date of an Offering Period, the
Committee may increase, but not decrease, the Option Price with respect to such Offering Period. The foregoing limitation on the
number of shares subject to an option hereunder and the Option Price will be subject to adjustment as provided in Article&nbsp;12.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">Notwithstanding the foregoing, the Committee may in its discretion
determine to implement Offering Periods of up to twenty-seven months. Such Offering Periods may consist of one or more Exercise
Dates. Each eligible employee who elects to be a participant in such Offering Period will be granted an option, at the Option Price,
to purchase shares of Common Stock on such Exercise Date(s). Each such option will cover a maximum number of shares of Common Stock
for such Offering Period as determined by the Committee prior the start date of such Offering Period. In no event will an Offering
Period under the Plan exceed twenty-seven months.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Except as otherwise determined by the Committee with respect to an
Offering Period prior to the start date thereof, unless a participant files a new authorization (as described in Article&nbsp;7)
or withdraws from the Plan (as described in Article&nbsp;10), the deductions and purchases under the authorization a participant
has on file under the Plan will continue from one Offering Period to succeeding Offering Periods as long as the Plan remains in
effect and the participant continues to be an eligible employee at the start date of the relevant Offering Period.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">For purposes of the Plan, the term &ldquo;Fair Market Value&rdquo;
on any date means the value of the Common Stock as determined below. If the Common Stock is listed on any established stock exchange
or a national market system, including without limitation, the New York Stock Exchange or the NASDAQ Stock Market, the Fair Market
Value will be the closing price of a share of Common Stock (or if no sales were reported on such date, the closing price on the
last trading date) as quoted on such exchange or system. In the absence of an established market for the Common Stock, the Fair
Market Value will be determined in good faith by the Committee and such determination will be conclusive and binding on all persons.
For purposes of the Plan, the term &ldquo;business day&rdquo; means a day on which there is trading on such exchange or system
and that is not a Saturday, Sunday or legal holiday in the State of Massachusetts.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">No employee will be granted an option which permits the employee&rsquo;s
right to purchase stock under the Plan, and under all other Code Section&nbsp;423(b) employee stock purchase plans of the Company
and any parent corporations or subsidiary corporations, as &ldquo;parent corporation&rdquo; and &ldquo;subsidiary corporation&rdquo;
are defined in Section&nbsp;424(e) and Section&nbsp;424(f) of the Code, to accrue at a rate which exceeds $25,000 of Fair Market
Value of such stock (determined on the date or dates that options on such stock were granted) for each calendar year in which such
option is outstanding at any time. The purpose of the limitation in the preceding sentence is to comply, and such limitation will
be administered in accordance, with Section&nbsp;423(b)(8) of the Code. If a participant&rsquo;s accumulated payroll deductions
on any Exercise Date would otherwise enable a participant to purchase Common Stock in excess of the Section&nbsp;423(b)(8) limitation
described in this paragraph, the excess of the amount of the accumulated payroll deductions over the aggregate purchase price of
the shares actually purchased will be promptly refunded to the participant by the Company, without interest.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;6 - Exercise of Option</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">Each eligible employee who continues to be a participant in the Plan
on an Exercise Date will be deemed to have exercised his or her option on such date and will be deemed to have purchased from the
Company such number of full shares of Common Stock reserved for the purpose of the Plan as the participant&rsquo;s accumulated
payroll deductions on such date will pay for at the Option Price, subject to the 800 maximum share limit of the option and the
Section&nbsp;423(b)(8) limitation described in Article&nbsp;5. If the individual is not a participant on an Exercise Date, then
he or she will not be entitled to exercise his or her option. Only full shares of Common Stock may be purchased under the Plan.
Except as otherwise determined by the Committee with respect to an Offering Period prior to the start date thereof, unused payroll
deductions remaining in a participant&rsquo;s account at the end of an Offering Period, by reason of the inability to purchase
a fractional share, will be carried forward to the next Offering Period.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;7 - Authorization for Entering the Plan</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">An employee may elect to enter the Plan by filling out, signing and
delivering to the Company an authorization form provided by the Company (including electronically), which will include the percentage
to be deducted regularly from the employee&rsquo;s pay, and any other terms or conditions as determined by the Committee in its
sole discretion, and authorizing the purchase of stock for the employee in each Offering Period in accordance with the terms of
the Plan.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Except as otherwise determined by the Committee with respect to an
Offering Period prior to the start date thereof, such authorization must be received by the Company (or made electronically) at
least ten (10) business days before the start date of the Offering Period to which it relates and will take effect only if the
employee is an eligible employee on the first business day of such Offering Period and otherwise meets the terms and conditions
of the Plan.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Except as otherwise determined by the Committee with respect to an
Offering Period prior to the start date thereof, unless a participant files a new authorization or withdraws from the Plan, the
deductions and purchases under the authorization the participant has on file under the Plan will continue from one Offering Period
to succeeding Offering Periods as long as the Plan remains in effect.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">The Company will accumulate and hold for each participant&rsquo;s
account the amounts deducted from his or her pay. No interest will be paid on these amounts. All payroll deductions received or
held by the Company under the Plan may be used by the Company for any corporate purpose, and the Company will not be obligated
to segregate such payroll deductions or hold them exclusively for the benefit of participants. All payroll deductions received
or held by the Company may be subject to the claims of the Company&rsquo;s general creditors. Participants will have the status
of general unsecured creditors of the Company. Any amounts payable to participants pursuant to the Plan will be unfunded and unsecured
obligations for all purposes, including, without limitation, Title I of the Employee Retirement Income Security Act of 1974, as
amended.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;8 - Maximum Amount of Payroll Deductions</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">Except as otherwise determined by the Committee with respect to an
Offering Period prior to the start date thereof, an employee may authorize payroll deductions in an amount (expressed as a whole
percentage) not less than one&nbsp;percent (1%) but not more than ten percent (10%) of the employee&rsquo;s Compensation. For this
purpose, &ldquo;Compensation&rdquo; means, unless otherwise determined by the Committee with respect to an Offering Period prior
to the start date thereof, an employee&rsquo;s base pay or salary from the Company or participating subsidiary, including such
amounts of base pay or salary as are deferred by the employee: (i) under a qualified cash or deferred arrangement described in
Section 401(k) of the Code; or (ii) to a plan qualified under Section 125 of the Code. Unless otherwise determined by the Committee
with respect to an Offering Period prior to the start date thereof, &ldquo;Compensation&rdquo; does not include overtime, bonuses,
annual awards, other incentive payments, reimbursements or other expense allowances, fringe benefits (cash or non-cash), moving
expenses, deferred compensation, contributions (other than contributions described in the preceding sentence) made on the employee&rsquo;s
behalf by the Company or a participating subsidiary under any employee benefit or welfare plan now or hereafter established, benefit
plan payments, short-term disability pay, long-term disability pay, maternity pay, military pay, tuition reimbursement and adoption
assistance, and any other payments not specifically referenced in the prior sentence.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;9 - Change in Payroll Deductions</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">Except as otherwise determined by the Committee with respect to an
Offering Period prior to the start date thereof, deductions may not be increased or decreased during an Offering Period.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;10 - Withdrawal from the Plan</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">Except as otherwise determined by the Committee with respect to an
Offering Period prior to the start date thereof, a participant may withdraw from the Plan and such Offering Period (in whole but
not in part) by giving notice (in the form provided by the Company from time to time, including electronically) at least three
business days prior to the end date of such Offering Period, in which case the Company will promptly refund, without interest,
the entire balance of his or her unused payroll deduction account under the Plan.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">Except as otherwise determined by the Committee with respect to an
Offering Period prior to the start date thereof, to re-enter the Plan, an employee who has previously withdrawn must file a new
authorization at least ten business days before the first day of the next Offering Period in which he or she wishes to participate.
The employee&rsquo;s re-entry into the Plan becomes effective at the beginning of such Offering Period, provided that he or she
is an eligible employee on the first business day of the Offering Period and otherwise meets the terms and conditions of the Plan.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">For the avoidance of doubt, any application of the maximum share
limitation set forth in Article 5 hereof, Code Section 423(b)(8) and fractional-share limitations on the amount of stock a participant
would be entitled to purchase will not constitute a withdrawal from the Plan.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;11 - Issuance of Stock</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">Stock purchased by participants under the Plan will be evidenced
in such a manner as the Company, in its discretion, deems appropriate, including, without limitation, book-entry or direct registration
or the issuance of one or more stock certificates. Stock purchased under the Plan will be issued only in the name of the relevant
participant.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;12 - Adjustments</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">Subject to any required action by the stockholders of the Company,
the Committee, in order to prevent dilution or enlargement of the benefits or potential benefits intended to be made available
under the Plan, will, in such manner as it may deem equitable, adjust the number of shares of Common Stock available for issuance
under the Plan, the Option Price, the maximum number of shares that may be purchased during an Offering Period, as well as any
other terms that the Committee determines require adjustment, for: (i) any increase or decrease in the number of issued shares
of Common Stock resulting from a stock split, reverse stock split, stock dividend, combination or reclassification of the Common
Stock; (ii) any other increase or decrease in the number of issued shares of Common Stock effected without receipt of consideration
by the Company; or (iii) as the Committee may determine in its discretion, any other transaction with respect to Common Stock,
including a corporate merger, consolidation, acquisition of property or stock, separation (including a spin-off or other distribution
of stock or property), reorganization, liquidation (whether partial or complete) or any similar transaction; provided, however,
that conversion of any convertible securities of the Company will not be deemed to have been &ldquo;effected without receipt of
consideration.&rdquo; Such adjustment, if any, will be made by the Committee and its determination will be final, binding and conclusive.
Except as the Committee determines otherwise, no issuance by the Company of shares of stock of any class, or securities convertible
into shares of stock of any class, will require adjustment hereunder. Notwithstanding the foregoing, any adjustments made pursuant
to this paragraph&nbsp;will be made only after the Committee, based on advice of counsel for the Company, determines whether such
adjustments would constitute a &ldquo;modification&rdquo; (as that term is defined in Section&nbsp;424 of the Code). If the Committee
determines that such adjustments would constitute a modification, it may refrain from making such adjustments.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Except as otherwise determined by the Committee, in the event of
a Change in Control (as defined in the Company&rsquo;s 2017 Omnibus Incentive Plan, as amended from time to time), all outstanding
options under the Plan will automatically be exercised immediately before the closing of such Change in Control as if the date
of such closing is the next Exercise Date, subject to the maximum share limitation set forth in Article 5 hereof, Code Section&nbsp;423(b)(8)
and fractional-share limitations on the amount of stock a participant would be entitled to purchase, and the Plan will terminate
immediately thereafter.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;13 - No Transfer or Assignment of Employee&rsquo;s Rights</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">An option granted under the Plan may not be transferred or assigned,
except by will or the laws of descent and distribution, and will be exercised, during a participant&rsquo;s lifetime, only by the
participant.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;14 - Termination of Employee&rsquo;s Rights</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">Whenever a participant ceases to be an eligible employee because
of retirement, voluntary or involuntary termination, resignation, layoff, discharge, death or for any other reason, his or her
rights under the Plan will immediately terminate, and the Company will promptly refund, without interest, the entire balance of
his or her payroll deduction account under the Plan. Notwithstanding the foregoing, eligible employment will be treated as continuing
intact while the participant is on military leave, sick leave, or other bona fide leave of absence (such as temporary employment
by the government) if the period of such leave does not exceed 3 months, or if longer, so long as the participant&rsquo;s right
to reemployment with the Company or the participating subsidiary is provided either by statute or by contract. If the period of
leave exceeds 3 months and the participant&rsquo;s right to reemployment with the Company or the participating subsidiary is not
provided either by statute or by contract, the employment relationship will be deemed to terminate on the first day immediately
following such three-month period.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;15 - Termination and Amendments to Plan</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">Unless terminated sooner as provided below, the Plan will terminate
on the tenth anniversary of its approval by the Company&rsquo;s stockholders. The Plan may be terminated at any time by the Board
but such termination will not affect options then outstanding under the Plan. The Plan will terminate in any case when all or substantially
all of the unissued shares of stock reserved for the purposes of the Plan have been purchased. If at any time shares of stock reserved
for the purpose of the Plan remain available for purchase but not in sufficient number to satisfy all then unfilled purchase requirements,
the available shares will be apportioned among participants in proportion to the amount of payroll deductions accumulated on behalf
of each participant that would otherwise be used to purchase stock, and the Plan will terminate. Upon such termination or any other
termination of the Plan, all payroll deductions not used to purchase stock will be refunded, without interest.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">The Committee or the Board may from time to time adopt amendments
to the Plan provided that, without the approval of the stockholders of the Company, no amendment may (i)&nbsp;increase the number
of shares that may be issued under the Plan; (ii)&nbsp;change the class of employees eligible to receive options under the Plan,
if such action would be treated as the adoption of a new plan for purposes of Section&nbsp;423(b) of the Code; or (iii)&nbsp;be
made if it would be treated as the adoption of a new plan for purposes of Section&nbsp;423(b) of the Code or would require stockholder
approval under the exchange listing rules applicable to the Company.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;16 - Limits on Sale of Stock Purchased under the Plan</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">The Committee will designate a financial services firm or other agent
to maintain accounts on behalf of participants who have purchased shares of Common Stock under the Plan (&ldquo;Designated Broker&rdquo;).
Promptly following each Exercise Date, the number of shares of Common Stock purchased by each participant will be deposited into
his or her account established in his or her name with the Designated Broker (&ldquo;ESPP Share Account&rdquo;). A participant
will be free to undertake a sale of the shares of Common Stock in his or her ESPP Share Account at any time, subject to compliance
with applicable laws and the Company&rsquo;s insider trading policy, but in the absence of such a sale, except as otherwise determined
by the Committee, the shares of Common Stock must remain in the participant&rsquo;s ESPP Share Account at the Designated Broker
until the holding period set forth in Section 423 of the Code (i.e., the later of one year from the Exercise Date and two years
from the start of the Offering Period corresponding to such Exercise Date) has been satisfied. With respect to shares of Common
Stock for which the holding period set forth in Section 423 of the Code have been satisfied, the participant may move those shares
of Common Stock to another brokerage account of the participant&rsquo;s choosing.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><B></B></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;17 - Participating Subsidiaries</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">The term &ldquo;participating subsidiary&rdquo; will mean any present
or future subsidiary of the Company, as that term is defined in Section&nbsp;424(f) of the Code, which is designated from time
to time by the Board to participate in the Plan. The Board will have the power to make such designation before or after the Plan
is approved by the stockholders. Any such currently designated participating subsidiary is listed on Annex A hereto, which may
be updated by the Board from time to time.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;18 - Optionees Not Stockholders</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">Neither the granting of an option to an employee nor the deductions
from his or her pay will constitute such employee a stockholder of the shares covered by an option until such shares have been
actually purchased by the employee. A participant will have no interest or voting right in shares covered by the participant&rsquo;s
option until such shares are actually purchased on the participant&rsquo;s behalf in accordance with the applicable provisions
of the Plan. Except as set forth in Article 12, no adjustment will be made for dividends, distributions or other rights for which
the record date is prior to the date of such purchase.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;19 - Application of Funds</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">The proceeds received by the Company from the sale of Common Stock
pursuant to options granted under the Plan will be used for general corporate purposes.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article 20 - Designation of Beneficiary</U></B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-indent: 0.5in; margin: 0pt 0">Each participant may file a designation (using such form or method
(including electronic forms) as the Committee may designate from time to time) of a beneficiary who is to receive any shares and
cash, if any, from the participant&rsquo;s account under the Plan in the event of such participant&rsquo;s death. If a participant
is married and the designated beneficiary is not the spouse, spousal consent will be required for such designation to be effective.
Such designation of beneficiary may be changed by the participant (and the participant&rsquo;s spouse, if any) at any time by written
notice (using such form or method (including electronic forms) as the Committee may designate from time to time). In the event
of the death of a participant and in the absence of a beneficiary validly designated under the Plan who is living (or in existence)
at the time of such participant&rsquo;s death, the Company will deliver such shares and/or cash to the executor or administrator
of the estate of the participant, or if no such executor or administrator has been appointed (to the knowledge of the Committee),
the Committee will deliver such shares and/or cash to the spouse (or domestic partner, as determined by the Committee) of the participant,
or if no spouse (or domestic partner) is known to the Committee, then to the issue of the participant, such distribution to be
made per stirpes (by right of representation), or if no issue are known to the Committee, then to the heirs at law of the participant
determined in accordance with applicable law.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="margin: 0pt 0; font-size: 10pt"><B></B></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;21 - Withholding of Additional Income Taxes</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">By electing to participate in the Plan, each participant acknowledges
that the Company and its participating subsidiaries are required to withhold taxes with respect to the amounts deducted from the
participant&rsquo;s compensation and accumulated for the benefit of the participant under the Plan, and each participant agrees
that the Company and its participating subsidiaries may deduct additional amounts from the participant&rsquo;s compensation, when
amounts are added to the participant&rsquo;s account, used to purchase Common Stock or refunded, in order to satisfy such withholding
obligations. Each participant further acknowledges that when Common Stock is purchased under the Plan the Company and its participating
subsidiaries may be required to withhold taxes with respect to all or a portion of the difference between the Fair Market Value
of the Common Stock purchased and its purchase price, and each participant agrees that such taxes may be withheld from compensation
otherwise payable to such participant. It is intended that tax withholding will be accomplished in such a manner that the full
amount of payroll deductions elected by the participant under Article&nbsp;7 will be used to purchase Common Stock. However, if
amounts sufficient to satisfy applicable tax withholding obligations have not been withheld from compensation otherwise payable
to any participant, then, notwithstanding any other provision of the Plan, the Company may withhold such taxes from the participant&rsquo;s
accumulated payroll deductions and apply the net amount to the purchase of Common Stock, unless the participant pays to the Company,
prior to the relevant Exercise Date, an amount sufficient to satisfy such withholding obligations. Each participant further acknowledges
that the Company and its participating subsidiaries may be required to withhold taxes in connection with the disposition of stock
acquired under the Plan and agrees that the Company or any participating subsidiary may take whatever action it considers appropriate
to satisfy such withholding requirements, including deducting from compensation otherwise payable to such participant an amount
sufficient to satisfy such withholding requirements or conditioning any disposition of Common Stock by the participant upon the
payment to the Company or such subsidiary of an amount sufficient to satisfy such withholding requirements.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;22 - Governmental Regulations</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">The Company&rsquo;s obligation to sell and deliver shares of Common
Stock under the Plan is subject to the approval of any governmental authority required in connection with the authorization, issuance
or sale of such shares.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">Government regulations may impose reporting or other obligations
on the Company with respect to the Plan. For example, the Company may be required to identify shares of Common Stock issued under
the Plan on its stock ownership records and send tax information statements to employees and former employees who transfer title
to such shares.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;23 - Governing Law</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">The validity and construction of the Plan will be governed by the
laws of Delaware, without giving effect to the principles of conflicts of law thereof.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B><U>Article&nbsp;24 - Approval of Board and Stockholders of the Company</U>.</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0; text-indent: 0.5in">The Plan was adopted by the Board on March 17, 2021 and was approved
by the stockholders of the Company on June 16, 2021.</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 4pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B><U>ANNEX A</U></B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B><U>DESIGNATED SUBSIDIARIES</U></B></P>

<P STYLE="font-size: 10pt; text-align: center; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font-size: 10pt; margin: 0pt 0">Arthrosurface, Inc.</P>

<P STYLE="font-size: 10pt; margin: 0pt 0">Parcus Medical, LLC</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt">12</P>

<P STYLE="margin: 0pt 0; font-size: 10pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 3pt auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0pt 0; font-size: 10pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>anik-20210616.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /KYps7xRiXgen8uGZX8sSaiFicPtwptyqZkhuWh7fdn6/yUn94oNnSaXtzkGQdYJ -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ANIK="http://ANIK/20210616" elementFormDefault="qualified" targetNamespace="http://ANIK/20210616">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://ANIK/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="anik-20210616_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="anik-20210616_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" />
    <import namespace="http://xbrl.ifrs.org/taxonomy/2020-03-16/ifrs-full" schemaLocation="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>anik-20210616_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInformationFormerLegalOrRegisteredName" xlink:to="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInformationFormerLegalOrRegisteredName_lbl" xml:lang="en-US">Entity Information, Former Legal or Registered Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>anik-20210616_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.5c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: http://www.novaworks.co -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://ANIK/role/Cover" xlink:href="anik-20210616.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://ANIK/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInformationFormerLegalOrRegisteredName" xlink:label="loc_deiEntityInformationFormerLegalOrRegisteredName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInformationFormerLegalOrRegisteredName" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>f8k_062121_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="anik-20210616.xsd" xlink:type="simple"/>
    <context id="From2021-06-16to2021-06-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000898437</identifier>
        </entity>
        <period>
            <startDate>2021-06-16</startDate>
            <endDate>2021-06-16</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-06-16to2021-06-16">0000898437</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-06-16to2021-06-16">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2021-06-16to2021-06-16">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2021-06-16to2021-06-16">2021-06-16</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2021-06-16to2021-06-16">Anika Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-06-16to2021-06-16">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2021-06-16to2021-06-16">000-21326</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2021-06-16to2021-06-16">04-3145961</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2021-06-16to2021-06-16">32 Wiggins Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2021-06-16to2021-06-16">Bedford</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2021-06-16to2021-06-16">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2021-06-16to2021-06-16">01730</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2021-06-16to2021-06-16">(781)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-06-16to2021-06-16">457-9000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2021-06-16to2021-06-16">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2021-06-16to2021-06-16">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2021-06-16to2021-06-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2021-06-16to2021-06-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2021-06-16to2021-06-16">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-06-16to2021-06-16">ANIK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-06-16to2021-06-16">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-06-16to2021-06-16">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm140539216770056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 16, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 16,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-21326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Anika Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000898437<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-3145961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">32 Wiggins Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Bedford<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(781)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">457-9000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ANIK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MCMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " #G@=92JL0B%C,!   B @  #P
M 'AL+W=O<FMB;V]K+GAM;(U1T6[", S\E2H?L!:T(0U17D#;D*8-C8GWT+K4
M(HDKQX6-KY_;JAK27O:4W-FZW%T6%^+3@>B4?'D78FYJD6:>IK&HP=MX1PT$
MG53$WHI"/J:Q8;!EK '$NW2:9;/46PQFN1BUMIS> A(H!"DHV1%[A$O\G7<P
M.6/$ SJ4[]ST=P<F\1C0XQ7*W&0FB35=7HCQ2D&LVQ5,SN5F,@SVP(+%'WK7
MF?RTA]@S8@\?5HWD9I:I8(4<I=_H]:UZ/(,N#Z@5>D(GP&LK\,S4-AB.G8RF
M2&]B]#V,YU#BG/]3(U45%K"FHO409.B1P74&0ZRQB28)UD-N5G0&[O+H YMR
MR"9JZJ8IGJ,.>%,.]D9/)508H'Q3F:B\]E-L.>F.7F=Z_S!YU!Y:YU;*O8=7
MLN48<?R>Y0]02P,$%     @ YX'64B0>FZ*M    ^ $  !H   !X;"]?<F5L
M<R]W;W)K8F]O:RYX;6PN<F5L<[61/0Z#, R%KQ+E #50J4,%3%U8*RX0!?,C
M$A+%K@JW+X4!D#IT8;*>+7_OR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C
M,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI
M160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%
MKLWC":[?#'!X=/X!4$L#!!0    ( .>!UE)ED'F2&0$  ,\#   3    6T-O
M;G1E;G1?5'EP97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^
MDV=:TMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT
M(3E)_)JV(DJUDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"
MS&I*&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE
M8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F
M"LC*30H1.;$$?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^D<WC_0QI-^2!8ECF
MS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ YX'64@=!
M36*!    L0   !               ( !     &1O8U!R;W!S+V%P<"YX;6Q0
M2P$"% ,4    " #G@=924B15;NX    K @  $0              @ &O
M9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #G@=92F5R<(Q &  "<)P
M$P              @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0
M   ( .>!UE+,3,*C- 0  #(0   8              " @0T(  !X;"]W;W)K
M<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #G@=92GZ ;\+$"  #B#
M#0              @ %W#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( .>!
MUE*7BKL<P    !,"   +              "  5,/  !?<F5L<R\N<F5L<U!+
M 0(4 Q0    ( .>!UE*JQ"(6,P$  "("   /              "  3P0  !X
M;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #G@=92)!Z;HJT   #X 0  &@
M            @ &<$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"
M% ,4    " #G@=9299!YDAD!  #/ P  $P              @ &!$@  6T-O
F;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #+$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="f8k_062121.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ANIK/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="f8k_062121.htm">f8k_062121.htm</File>
    <File>anik-20210616.xsd</File>
    <File>anik-20210616_lab.xml</File>
    <File>anik-20210616_pre.xml</File>
    <File>exh_991.htm</File>
    <File>exh_992.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "f8k_062121.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "f8k_062121.htm"
     ]
    },
    "labelLink": {
     "local": [
      "anik-20210616_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "anik-20210616_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "anik-20210616.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd"
     ]
    }
   },
   "elementCount": 60,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ANIK",
   "nsuri": "http://ANIK/20210616",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "f8k_062121.htm",
      "contextRef": "From2021-06-16to2021-06-16",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://ANIK/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "f8k_062121.htm",
      "contextRef": "From2021-06-16to2021-06-16",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r9",
      "r11",
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Legal or Registered Name of an entity",
        "label": "Entity Information, Former Legal or Registered Name"
       }
      }
     },
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://ANIK/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r10": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r11": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r12": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r13": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r14": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r15": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r16": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "Section",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001171843-21-004469-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001171843-21-004469-xbrl.zip
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M=7Y* IAMG9X8NJ!H <S!IRV5/@1>EH\D3>4M!$S[!Q>;V#4SL&&3FK8R*&Y
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M.L=#T3D.&IWC#Z$CNC^ <6<N/M[P>_9J>S0<5'H!IVW5BLU>%AXT+6]]R,@
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M\'<A9 GQ!!)H'L"II0\1*LAD+UHJT#]A2Q)MQ;SY-IVM[I,\M9V&MB7.9BG
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M6;9V'#(U?JYN(/9NN\RP*6DK15D597"2Z)S6193FYPGL-=R/43+.YEE]-1S
MCL2_#XK%,LFOHB2?T@X=S6;P0%+#A0&_3&I8R$E-WY9IG<"F/H>UGE]%_]M
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M%$RV[F89=ZO&6O,4XY#HW2A*)DM;EEJ1C^A/5PL@5VE(ZJCPI.CS-\U1#;=
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M3JVLERE$2\1R20_:?0M%T%T18P<@\\E_L:4TY?]L.3",3"#Z0;0LT=N"6YD
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MJZMD'.?=C<CV-D[19>&VF;K+NN/3@GOR=BD%X'0QW%/7WAIDWG<&U[-77*S
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M5"E?;*92'A_^WS^.C@^1M(HR3-^._KE%VN2+^^*FVC(1==HA5A<IXV( 2O&
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M!9_58T*C;YDB\JXP/%GBK%>:K/ZL'A-\=T6:M/(23)3CN36>!R_[" R^P.(
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M=.VD4 ;16N4G:NL^]V/(W(D6])X38Y_>P([!/%BI4TTSHW]%A[Z6T5;FQH(
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M@QJAA2Z+!E86K7B$'CNOP[A1W>,7:!O#*R!A<\4^3I(L4V:&IO $%R*ZZ:-
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MI%JKE7RJ&P[ICY:4+?B,P5_@"X,AG.R(BU$#.S)B+>1=*J&:LUL(I@:O!$N
M[&O)_\ @S.??'H3Y_!'"O*$*]A.H8.\X>@1X]5'UZCE: L4*-2\QKFS0?\8G
MK?V0-9SIU#G"OJZ_=V\7UOGO@E; .1?!%8]KW,)\<)DMM-.*0G51')T$0%<O
M! YB+"54VZHA$QSSN::R)/ UQAIL:9O*N0$;[Z2SA>IC%[^4XG;ULD*=*@8O
MH_F':6-]4YGZ$)EY*FE.$;S0BG_HQC9(G134G>#,GX$R*Q%] <H2NR>#8M(6
MJ_G32J7\VS EW7:Q';ME8DO09GZ"BG>AN52BY5O!P@D[)/02=)DX[MEQ#-AQ
M@U@W8\T",0_Y9#W#A)YV^-.TZB;NC$=G?08B3Y/O"PG E)E",,,(#$DQE[4
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MDO'6"-[W,SG/R_AZ XP$L![M4'>91@EL;B--G2[>FQ&4ZX5B+P2='RQ3_BQ
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MW'\6^QZ6@7(E"$B7.K6HH%8/S-EPMHRK#P^AF=8E3P<<YF!SP5JTDO'<0[=
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MV.+HXAJ;M\_'5T=+I*/+$-R(0)T-=DY=7+OC#2<['YG,'TN"K4ZYC977O$Y
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MMR5U 3DNQ1@080IER,6V^RB&]?5DL2B)P%!N52VX*O78< !6E&ZP>@$D:3X
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M\ZEZ400:FLIG+H[_ U!+ 0(4 Q0    ( .>!UE)T*O&Y& ,  ,8*   1
M          "  0    !A;FEK+3(P,C$P-C$V+GAS9%!+ 0(4 Q0    ( .>!
MUE*3?GLR-PL  (R*   5              "  4<#  !A;FEK+3(P,C$P-C$V
M7VQA8BYX;6Q02P$"% ,4    " #G@=92&0F+L7,'  #:6@  %0
M    @ &Q#@  86YI:RTR,#(Q,#8Q-E]P<F4N>&UL4$L! A0#%     @ YX'6
M4JP.IH$!9@  ;G0"  L              ( !5Q8  &5X:%\Y.3$N:'1M4$L!
M A0#%     @ YX'64NQ,'6VL*0  A,X   L              ( !@7P  &5X
M:%\Y.3(N:'1M4$L! A0#%     @ YX'64GHCV]Y$&   ))<   X
M     ( !5J8  &8X:U\P-C(Q,C$N:'1M4$L%!@     &  8 <P$  ,:^
!  $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
